<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Current Allergy and Asthma Reports via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Current Allergy and Asthma Reports' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Current+Allergy+and+Asthma+Reports&t=Current+Allergy+and+Asthma+Reports&s=Search&f=source]]></link>
        <lastBuildDate>Sat, 20 Mar 2010 13:39:23 +0100</lastBuildDate>
        <item>
            <title>Rhinosinusitis and Comorbidities</title>
            <link>http://www.medworm.com/index.php?rid=3371232&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk312g2kn55437564%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A variety of systemic conditions impact the incidence, severity, prognosis, and treatment approach in patients with chronic
 rhinosinusitis (CRS). The controversy surrounding the impact of allergic rhinitis on CRS continues, but it is reasonable to
 consider and treat allergic sources of inflammation in any patient with CRS. CRS is more severe in patients with aspirin sensitivity
 but improves—at least temporarily—to the same degree as in non-aspirin-sensitive patients, given appropriate therapy. Polypoid
 rhinosinusitis in cystic fibrosis patients is characterized by compromised mucociliary clearance and infection with staphylococcal
 and pseudomonal organisms. Affected individuals require frequent antibiotic treatment, saline lavage, and repeated surgeries.
 Rhino...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3371232</comments>
            <pubDate>Mon, 15 Mar 2010 18:00:24 +0100</pubDate>
            <guid isPermaLink="false">3371232</guid>        </item>
        <item>
            <title>Occupational Rhinitis</title>
            <link>http://www.medworm.com/index.php?rid=3355408&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg7002u3v7117471l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Work-related rhinitis, which includes work-exacerbated rhinitis and occupational rhinitis, may be two to three times more
 common than occupational asthma. Both high molecular weight proteins and low molecular weight chemicals have been implicated
 as causes of occupational rhinitis. A diagnosis is established based on occupational history and, if appropriate, documentation
 of IgE-mediated sensitization to the causative agent. Management of work-related rhinitis is similar to that of non-work-related
 rhinitis and includes elimination or reduction of exposure to offending agents combined with pharmacotherapy. If treatment
 allergens are commercially available, allergen immunotherapy may also be considered if appropriate.
 
 
	Content Type Journal ArticleDOI 10.1007/s11...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3355408</comments>
            <pubDate>Wed, 10 Mar 2010 16:11:12 +0100</pubDate>
            <guid isPermaLink="false">3355408</guid>        </item>
        <item>
            <title>Occupational Rhinosinusitis and Upper Airway Disease: The World Trade Center Experience</title>
            <link>http://www.medworm.com/index.php?rid=3355407&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq08hk17017842n10%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The World Trade Center disaster and its recovery work involved a range of hazardous occupational exposures that have not been
 fully characterized but that can be reasonably assumed to have the potential to cause mucosal inflammation, preferentially
 (but not exclusively) in the upper airway. A high prevalence of rhinosinusitis and upper airway disease (UAD) symptoms was
 reported by several early surveys. Clinical studies demonstrated objective, clinically significant, and persistent chronic
 perennial rhinosinusitis and UAD—with or without seasonal exacerbation—in a large proportion of patients. Demonstration of
 an association between UAD and available exposure indicators has been limited. Atopy seemed to be associated with increased
 UAD symptom severity and to ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3355407</comments>
            <pubDate>Wed, 10 Mar 2010 16:11:12 +0100</pubDate>
            <guid isPermaLink="false">3355407</guid>        </item>
        <item>
            <title>Allergic Conjunctivitis and the Impact of Allergic Rhinitis</title>
            <link>http://www.medworm.com/index.php?rid=3355406&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1312j4uu410k2545%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although nasal allergy has been prominent in allergy research, ocular allergy is increasingly recognized as a distinct symptom
 complex that imposes its own disease burden and reduction in patients’ quality of life. In the past year, knowledge of the
 relationships between allergic conjunctivitis and allergic rhinitis has increased. Allergic conjunctivitis is highly prevalent
 and has a close epidemiologic relationship with allergic rhinitis. Both conditions also exhibit similar pathophysiologic mechanisms.
 Pathways of communication are thought to increase the likelihood of an inflammatory reaction at both sites following allergen
 exposure of nasal or ocular tissue. Clinical trials of intranasal therapies have demonstrated efficacy in allergic conjunctivitis
 and rh...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3355406</comments>
            <pubDate>Wed, 10 Mar 2010 16:11:12 +0100</pubDate>
            <guid isPermaLink="false">3355406</guid>        </item>
        <item>
            <title>Historical, Pathophysiological, and Therapeutic Aspects of Vidian Neurectomy</title>
            <link>http://www.medworm.com/index.php?rid=3312567&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F106g28313216245l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Vidian neurectomy yields dramatic relief of nasal hypersecretion in patients with allergic rhinitis. Clinical studies conducted
 on vidian neurectomized nasal mucosa have shown that nasal hypersecretion observed after challenging the nasal mucosa with
 antigen is caused by reflexively induced activation of the parasympathetic center secondary to stimulation of the sensory
 nerve terminals in the nasal mucosa by histamine. On the contrary, nasal mucosal swelling is caused mostly by the direct effects
 of chemical mediators on the nasal vasculature, although vascular reflex mediated by the noncholinergic parasympathetic nerve
 may be partially involved in the onset of nasal mucosal swelling after antigen challenge. Considering the long-term side effects
 of inhibition of ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3312567</comments>
            <pubDate>Thu, 25 Feb 2010 08:02:50 +0100</pubDate>
            <guid isPermaLink="false">3312567</guid>        </item>
        <item>
            <title>Occupational Rhinitis and Asthma: Where Do We Stand, Where Do We Go?</title>
            <link>http://www.medworm.com/index.php?rid=3312568&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0w60504x0832116w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This review provides an overview of current and emerging issues regarding occupational rhinitis (OR) and occupational asthma
 (OA), focusing on studies discussing concepts and results that are relevant to both diseases. OA and OR are conditions that
 affect the upper and lower airways, are characterized by reduced airway caliber and hyperresponsiveness and by inflammation,
 and are caused by agents present in the workplace. To explain disease expression, research is moving from the T-helper type
 1/type 2 cells paradigm to consider the contribution of diverse alternative pathways such as neural inflammation, a dysfunctional
 epithelial barrier, and autoimmune mechanisms, among others. Objective assessment of OR and OA has been improved and tested
 for research and, curr...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3312568</comments>
            <pubDate>Thu, 25 Feb 2010 08:02:49 +0100</pubDate>
            <guid isPermaLink="false">3312568</guid>        </item>
        <item>
            <title>Vasomotor Rhinitis</title>
            <link>http://www.medworm.com/index.php?rid=3303515&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft42r671k36585u47%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Vasomotor rhinitis is a common disorder that is seen routinely in allergy practice. It affects millions of Americans and results
 in significant morbidity. The pathophysiology of this complex heterogeneous disorder is unknown, but we are making advances
 in this regard. Symptoms and signs can closely resemble those of allergic rhinitis and can be difficult to differentiate from
 those resulting from allergy. A careful history, physical examination, and diagnostic testing help clinicians arrive at a
 definitive diagnosis, but treatment can be challenging. Therapy should be based on the presenting symptoms of vasomotor rhinitis.
 Combination therapy with topical corticosteroids and azelastine is useful. However, in patients whose predominant symptom
 is rhinorrhea, use of...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3303515</comments>
            <pubDate>Tue, 23 Feb 2010 08:08:20 +0100</pubDate>
            <guid isPermaLink="false">3303515</guid>        </item>
        <item>
            <title>Congestion and Sleep Impairment in Allergic Rhinitis</title>
            <link>http://www.medworm.com/index.php?rid=3303514&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkpu746g137312p10%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Allergic rhinitis is a prevalent disease in developed nations, and its prevalence has been increasing throughout the world.
 Nasal congestion is the most common and bothersome symptoms of rhinitis. Congestion is associated with sleep-disordered breathing
 and is thought to be a key cause of sleep impairment in individuals with rhinitis. The end result is a decrease in quality
 of life and productivity and an increase in daytime sleepiness. Treatment with intranasal corticosteroids has been shown to
 reduce nasal congestion. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that
 this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Other therapies,
 such as montelukast, also ha...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3303514</comments>
            <pubDate>Tue, 23 Feb 2010 08:08:20 +0100</pubDate>
            <guid isPermaLink="false">3303514</guid>        </item>
        <item>
            <title>Immunosuppression Medication as an Approach to Treat Chronic Idiopathic Urticaria in Children</title>
            <link>http://www.medworm.com/index.php?rid=3190240&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fewq74412886gh005%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trial ReportDOI 10.1007/s11882-009-0084-4Authors
		Nora Daher, University of Tennessee at Memphis Memphis TN USAPhillip Lieberman, University of Tennessee College of Medicine at Memphis Memphis TN USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3190240</comments>
            <pubDate>Fri, 15 Jan 2010 18:06:01 +0100</pubDate>
            <guid isPermaLink="false">3190240</guid>        </item>
        <item>
            <title>The Role of Regulatory T Cells in Respiratory Infections and Allergy and Asthma</title>
            <link>http://www.medworm.com/index.php?rid=3176874&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F94867n4140475720%2F</link>
            <description>This article focuses on the role of Treg cells in the lungs following infection with respiratory
 pathogens and discusses the targeting of Treg cells in the development of new therapies for immune-mediated respiratory diseases,
 such as allergy and asthma.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0078-2Authors
		Peter McGuirk, Trinity College School of Biochemistry and Immunology Dublin 2 IrelandSarah C. Higgins, Trinity College School of Biochemistry and Immunology Dublin 2 IrelandKingston H. G. Mills, Trinity College School of Biochemistry and Immunology Dublin 2 Ireland
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3176874</comments>
            <pubDate>Wed, 13 Jan 2010 17:55:08 +0100</pubDate>
            <guid isPermaLink="false">3176874</guid>        </item>
        <item>
            <title>Anaphylaxis and Mast Cell Disease: What Is the Risk?</title>
            <link>http://www.medworm.com/index.php?rid=3160514&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk609385778h73gq7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mastocytosis is a proliferative disorder of the hematopoietic mast cell progenitor that results from expansion of a clone
 carrying the D816V c-kit mutation. Based on the dramatic increase in incidence of anaphylaxis in patients with mastocytosis, recent studies analyzed
 the presence of clonal mast cell markers, including D816V c-kit mutation, in patients with recurrent IgE- and non-IgE-mediated anaphylaxis. These studies demonstrated the presence of an
 aberrant mast cell clone in a significant proportion of patients with unexplained anaphylaxis, or anaphylaxis due to hymenoptera
 venom. Clonal mast cell disease should be suspected in particular in patients presenting with profound cardiovascular manifestations
 such as hypotension and syncope in the absence of urtica...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3160514</comments>
            <pubDate>Thu, 07 Jan 2010 22:26:36 +0100</pubDate>
            <guid isPermaLink="false">3160514</guid>        </item>
        <item>
            <title>Lyme Disease: A Review</title>
            <link>http://www.medworm.com/index.php?rid=3160515&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj708837847p73387%2F</link>
            <description>This article reviews the pathogenesis, epidemiology, clinical manifestations, diagnosis, treatment, and prevention of Lyme
 disease.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0077-3Authors
		Adriana R. Marques, National Institutes of Health Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases Building 10, Room 11 N234, 10 Center Drive Bethesda MD 20892 USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3160515</comments>
            <pubDate>Thu, 07 Jan 2010 22:26:35 +0100</pubDate>
            <guid isPermaLink="false">3160515</guid>        </item>
        <item>
            <title>Update on Infection and Antibiotics in Asthma</title>
            <link>http://www.medworm.com/index.php?rid=3154072&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbk81l5p332707457%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Asthma pathogenesis seems to be a result of a complex mixture of genetic and environmental influences. There is evidence that
 Mycoplasma pneumoniae and Chlamydophila pneumoniae (formerly known as Chlamydia pneumoniae) play a role in promoting airway inflammation that could contribute to the onset and clinical course of asthma. Evidence
 also indicates that when antimicrobial therapy can eradicate or suppress these organisms, it may be possible to alter the
 course of the disease. Certain macrolide antibiotics have been shown to improve control of asthma symptoms and lung function
 in patients diagnosed with acute C. pneumoniae or M. pneumoniae infection. Positive polymerase chain reaction studies for C. pneumoniae or M. pneumoniae are needed to select asthma patients f...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154072</comments>
            <pubDate>Wed, 06 Jan 2010 18:09:24 +0100</pubDate>
            <guid isPermaLink="false">3154072</guid>        </item>
        <item>
            <title>Chronic Helminth Infections Protect Against Allergic Diseases by Active Regulatory Processes</title>
            <link>http://www.medworm.com/index.php?rid=3154073&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff712l1l63w2tq260%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Developed countries are suffering from an epidemic rise in immunologic disorders, such as allergy-related diseases and certain
 autoimmunities. Several studies have demonstrated a negative association between helminth infections and inflammatory diseases
 (eg, allergy), providing a strong case for the involvement of helminth infections in this respect. However, some studies point
 in the opposite direction. The discrepancy may be explained by differences in frequency, dose, time, and type of helminth.
 In this review, new studies are discussed that may support the concept that chronic helminth infections in particular—but
 not acute infections—are associated with the expression of regulatory networks necessary for downmodulating allergic immune
 responses to harmles...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154073</comments>
            <pubDate>Tue, 05 Jan 2010 17:03:01 +0100</pubDate>
            <guid isPermaLink="false">3154073</guid>        </item>
        <item>
            <title>Pathogenesis of Allergic Airway Inflammation</title>
            <link>http://www.medworm.com/index.php?rid=3134265&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy748722781223126%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Advances have been made in defining the mechanisms for the control of allergic airway inflammation in response to inhaled
 antigens. Several genes, including ADAM33, DPP10, PHF11, GPRA, TIM-1, PDE4D, OPN3, and ORMDL3, have been implicated in the pathogenesis and susceptibility to atopy and asthma. Growing evidence associates asthma with
 a systemic propensity for allergic T-helper type 2 cytokines. Disordered coagulation and fibrinolysis also exacerbate asthma
 symptoms. Balance among functionally distinct dendritic cell subsets contributes to the outcome of T-cell-mediated immunity.
 Allergen-specific T-regulatory cells play a pivotal role in the development of tolerance to allergens and immune suppression.
 The major emphasis on immunotherapy for asthma during the pas...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3134265</comments>
            <pubDate>Wed, 30 Dec 2009 06:49:10 +0100</pubDate>
            <guid isPermaLink="false">3134265</guid>        </item>
        <item>
            <title>Managing Outpatient Asthma Exacerbations</title>
            <link>http://www.medworm.com/index.php?rid=3127303&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj4h44k715r384367%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Asthma is a chronic inflammatory disease that renders individuals vulnerable to acute exacerbations. A wide variety of allergic
 and nonallergic triggers can incite an asthma exacerbation. The goals of managing an asthma exacerbation are prompt recognition,
 rapid reversal of airflow obstruction, avoidance of relapses, and prevention of future episodes. A written asthma home management
 plan is essential to minimize the severity of exacerbations. Short-acting β-agonists, oxygen, and corticosteroids remain fundamental
 to early intervention in acute asthma exacerbations. Anticholinergics and magnesium sulfate can help nonresponders. Combination
 inhalers of the long-acting β-agonist formoterol and inhaled steroid budesonide have been effective in flexible dosing in
 tr...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127303</comments>
            <pubDate>Mon, 28 Dec 2009 17:54:33 +0100</pubDate>
            <guid isPermaLink="false">3127303</guid>        </item>
        <item>
            <title>Allergenicity of Carbohydrates and Their Role in Anaphylactic Events</title>
            <link>http://www.medworm.com/index.php?rid=3122708&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg8066030h683362r%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The IgE response to pollen allergens often includes IgE antibodies specific for glycosylation motifs on the pollen proteins.
 These oligosaccharides are present on many different species and are known as cross-reactive carbohydrate determinants. However, IgE antibodies to plant-derived cross-reactive carbohydrate determinants seem to have only minor clinical significance
 and have not been related to anaphylaxis. Recently, two novel forms of anaphylaxis have become apparent in the southeastern
 United States: 1) reactions during the first infusion of the monoclonal antibody cetuximab and 2) adult-onset delayed anaphylaxis
 to red meat. Detailed investigation of serum antibodies established that in both cases, the patients had IgE antibodies specific
 for the mammalian o...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3122708</comments>
            <pubDate>Thu, 24 Dec 2009 19:49:42 +0100</pubDate>
            <guid isPermaLink="false">3122708</guid>        </item>
        <item>
            <title>Does Exposure to Indoor Allergens Contribute to the Development of Asthma and Allergy?</title>
            <link>http://www.medworm.com/index.php?rid=3122707&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq77l1u40p8505qm8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Common indoor allergens include house dust mite, cockroach, animal dander, and certain molds. In genetically susceptible children,
 exposure to these indoor allergens during the critical postnatal period may lead to sensitization in early childhood. Consistent
 evidence indicates that children sensitized to common indoor allergens are at several-fold higher risk of asthma and allergy.
 Due to conflicting evidence from prospective studies, some doubt remains regarding a direct and dose–response relationship
 between exposure and development of asthma. However, in recent years, evidence has accumulated that exposure to indoor allergen
 causes asthma and allergy, but this effect may depend on dose and type of allergen as well as the underlying genetic susceptibility
 of ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3122707</comments>
            <pubDate>Thu, 24 Dec 2009 19:49:42 +0100</pubDate>
            <guid isPermaLink="false">3122707</guid>        </item>
        <item>
            <title>Genotype at increased risk of developing asthma after tobacco smoke exposure</title>
            <link>http://www.medworm.com/index.php?rid=2895620&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn5780w47x75266t0%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0074-6Authors
		Christina E. Ciaccio, Children’s Mercy Hospitals and Clinics Section of Allergy, Asthma, and Immunology Kansas USAJay M. Portnoy, Children’s Mercy Hospitals and Clinics Section of Allergy, Asthma, and Immunology Kansas USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 6 / November, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895620</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:38 +0100</pubDate>
            <guid isPermaLink="false">2895620</guid>        </item>
        <item>
            <title>Self-management improves asthma</title>
            <link>http://www.medworm.com/index.php?rid=2895619&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7516505133100385%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0072-8Authors
		Christina E. Ciaccio, Children’s Mercy Hospitals and Clinics Section of Allergy, Asthma, and Immunology Kansas USAJay M. Portnoy, Children’s Mercy Hospitals and Clinics Section of Allergy, Asthma, and Immunology Kansas USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 6 / November, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895619</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:38 +0100</pubDate>
            <guid isPermaLink="false">2895619</guid>        </item>
        <item>
            <title>Should antibiotics be given to children with otitis media to prevent mastoiditis?</title>
            <link>http://www.medworm.com/index.php?rid=2895622&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmm78xl373634t6x2%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0075-5Authors
		David P. Skoner, Drexel University College of Medicine Philadelphia USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 6 / November, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895622</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:37 +0100</pubDate>
            <guid isPermaLink="false">2895622</guid>        </item>
        <item>
            <title>Potential new paradigm for treatment of atopic dermatitis</title>
            <link>http://www.medworm.com/index.php?rid=2895621&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F64w7008p12111730%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0073-7Authors
		Christina E. Ciaccio, Children’s Mercy Hospitals and Clinics Section of Allergy, Asthma, and Immunology Kansas USAJay M. Portnoy, Children’s Mercy Hospitals and Clinics Section of Allergy, Asthma, and Immunology Kansas USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 6 / November, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895621</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:37 +0100</pubDate>
            <guid isPermaLink="false">2895621</guid>        </item>
        <item>
            <title>Otitis media and antihistamines</title>
            <link>http://www.medworm.com/index.php?rid=2895623&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd36j4238h8113640%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Otitis media with effusion (OME) and acute otitis media (AOM) continue to be a significant source of morbidity in the United
 States, as they account for more than 3.5 billion dollars in annual costs, and OME is the sixth most common reason for an
 emergency department visit. The efficacy of antihistamines in the treatment of OME/AOM has been thoroughly refuted in the
 literature during the past three decades. However, most studies to date have used first-generation antihistamines with or
 without decongestants. We propose that second-generation antihistamines may have increased efficacy in the treatment of OME/AOM
 because of their greater selectivity for histamine receptors and lack of anti-cholinergic activity. Further clinical trials
 may be warranted, as medical tr...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895623</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:36 +0100</pubDate>
            <guid isPermaLink="false">2895623</guid>        </item>
        <item>
            <title>Role of adenoids and adenoiditis in children with allergy and otitis media</title>
            <link>http://www.medworm.com/index.php?rid=2895625&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcn7x81126554721p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Adenoids and/or tonsil inflammation with concomitant obstructive hypertrophy is one of the oldest and most common pediatric
 problems. Adenoids are a component of Waldeyer’s ring and because of their anatomic position can be relevant in the pathogenesis
 of otitis media when they are inflamed and/or enlarged. Adenoid pads can create mechanical eustachian tube obstruction. Therefore,
 in some cases, adenoidectomy may have a role in the clinical management of otitis media with effusion. However, eustachian
 tube dysfunction related to the adenoids may also have an allergy-related functional component. Allergic inflammation has
 been described for middle ear effusion, and some studies have reported that mast cells increase and allergic mediators release
 in adenoids as w...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895625</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:35 +0100</pubDate>
            <guid isPermaLink="false">2895625</guid>        </item>
        <item>
            <title>Relationship between pediatric obesity and otitis media with effusion</title>
            <link>http://www.medworm.com/index.php?rid=2895624&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv3821q5888108615%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although eustachian tube dysfunction and bacterial infection have been shown to cause otitis media with effusion (OME), other
 etiologies are possible. One of the most common medical conditions in children is obesity, which can have effects throughout
 the body. Little is known, however, about the relationship between obesity and OME. Obesity may result in altered cytokine
 expression, gastroesophageal reflux disease, or fat accumulation, all of which may contribute to OME. Conversely, OME may
 induce taste changes through middle ear cavity inflammation, thus contributing to obesity. A similar pattern of taste change
 has been shown in patients with gustatory nerve anesthesia. Further research on the relationship between obesity and OME may
 help to determine the exact ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895624</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:35 +0100</pubDate>
            <guid isPermaLink="false">2895624</guid>        </item>
        <item>
            <title>Asthma phenotypes</title>
            <link>http://www.medworm.com/index.php?rid=2895627&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F374556192tj05535%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The many roads leading to the syndrome of asthma have proven to be intricately interconnected. The chronic inflammation of
 asthma is characterized by airway hyperreactivity and variable reversibility. Past classification systems relied on assessment
 of daily impairment and the distinction between intrinsic (nonallergic) and extrinsic (allergic). With more precise asthma
 phenotypes, association studies likely will have greater significance. In addition, patients at higher risk for severe disease
 can be more effectively managed, and treatments can be directed to responders. In this review, we look at eight identified
 phenotypes: atopic and nonatopic status, pre-asthma wheezing, inflammatory mediator predominance, aspirin-sensitive, exercise-induced,
 severe, and flar...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895627</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:33 +0100</pubDate>
            <guid isPermaLink="false">2895627</guid>        </item>
        <item>
            <title>Home and school environmental assessment and remediation</title>
            <link>http://www.medworm.com/index.php?rid=2895626&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk5t6155g6538qx14%2F</link>
            <description>This article reviews and discusses evidence for the assessment and remediation of indoor allergens commonly found in homes
 and schools. A literature review was performed using the PubMed database for English-language articles published between January
 1, 1980, and February 2009. Additional information was obtained from a review of recent textbooks and one professional society’s
 webpage.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0062-xAuthors
		Thomas A. Lupoli, Children’s Mercy Hospital 2401 Gillham Road Kansas City MO 64108 USAChristina E. CiaccioJay M. Portnoy
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 6 / November, 2009 (Source: Current Allergy and Asthma Rep...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895626</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:33 +0100</pubDate>
            <guid isPermaLink="false">2895626</guid>        </item>
        <item>
            <title>Immunomodulators in asthma therapy</title>
            <link>http://www.medworm.com/index.php?rid=2895628&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj267631pt371851l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;New developments in the field of allergy and immunology have yielded a variety of novel therapeutic approaches in recent years,
 and more agents are at the clinical trial stage. Among the therapeutic approaches discussed in this review are Toll-like receptor
 agonists, immunostimulatory oligodeoxynucleotides, orally and parenterally administered cytokine blockers, and specific cytokine
 receptor antagonists. Transcription factor modulators targeting syk kinase, peroxisome proliferator-activated receptor-γ,
 and nuclear factor-κB are also being evaluated in the treatment of asthma. The anti-IgE monoclonal antibody omalizumab has
 established effectiveness in patients with allergic asthma, but the criteria for selecting patients who are most likely to
 benefit from it a...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895628</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:32 +0100</pubDate>
            <guid isPermaLink="false">2895628</guid>        </item>
        <item>
            <title>An update on exercise-induced bronchoconstriction with and without asthma</title>
            <link>http://www.medworm.com/index.php?rid=2895631&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh520285307388111%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Exercise-induced bronchoconstriction (EIB) is defined as transient, reversible bronchoconstriction that develops after strenuous
 exercise. It is a heterogeneous syndrome made up of a spectrum of phenotypes ranging from the asymptomatic military recruit
 whose condition is detected by diagnostic exercise challenge to the athlete with known asthma to the elite athlete for whom
 EIB represents an overuse or injury syndrome. If exercise is the only identified trigger for bronchoconstriction, it is called
 EIB. However, when it is associated with known asthma, then it is defined as EIB with asthma. This review discusses the pathogenesis,
 presentation, diagnosis, and management of EIB and EIB with asthma.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0064-8Authors
	...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895631</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:31 +0100</pubDate>
            <guid isPermaLink="false">2895631</guid>        </item>
        <item>
            <title>Neural control of airway inflammation</title>
            <link>http://www.medworm.com/index.php?rid=2895630&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9545qg4522503167%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Abnormal neural function contributes to the pathogenesis of airway disease. In addition to affecting airway physiology, the
 nerves produce and release inflammatory mediators, contributing to the recruitment and activation of leukocytes. Activated
 inflammatory cells in turn affect the function of airway nerves, changing the production and release of neurotransmitters.
 Cross-talk between airway nerves and leukocytes helps to maintain chronic inflammation and accentuates neural control of the
 airways.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0071-9Authors
		Kirsten C. VerheinAllison D. FryerDavid B. Jacoby, Oregon Health &amp; Science University Department of Medicine 3181 Southwest Sam Jackson Park Road, Mail Code UHN67 Portland OR 97239 USA
	

	
		Journal Cu...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895630</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:31 +0100</pubDate>
            <guid isPermaLink="false">2895630</guid>        </item>
        <item>
            <title>Biofilms in pediatric respiratory and related infections</title>
            <link>http://www.medworm.com/index.php?rid=2895629&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Frh0606633653r084%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Bacteria can grow as free-floating, planktonic bacteria or complex communities called biofilms. Biofilms promote bacterial
 growth and diversity and offer bacteria unique environments, including aerobic and anaerobic layers, that facilitate resistance
 to antimicrobial therapies. Respiratory and related structures provide ideal environments for the development of bacterial
 biofilms, which predispose patients to recurrent and chronic infections. Biofilms are important for the persistence of chronic
 rhinosinusitis, pulmonary infections in cystic fibrosis, chronic otitis media, and device-related infections. Antimicrobial
 therapy that is proven effective against planktonic bacteria is often insufficiently effective against the defenses of biofilms.
 Furthermore, biofilm...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895629</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:31 +0100</pubDate>
            <guid isPermaLink="false">2895629</guid>        </item>
        <item>
            <title>Effects of allergens: Beyond IgE</title>
            <link>http://www.medworm.com/index.php?rid=2895633&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F82m4066338554j27%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0076-4Authors
		Robert K. Bush, University of Wisconsin-Madison Wisconsin-Madison USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 6 / November, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895633</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:29 +0100</pubDate>
            <guid isPermaLink="false">2895633</guid>        </item>
        <item>
            <title>Personalized medicine: A pediatric perspective</title>
            <link>http://www.medworm.com/index.php?rid=2895632&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F800t841644377520%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of pediatric personalized medicine is to uniquely combine genetic variation with developmental stage and environmental
 exposure to provide a tailored preventive, diagnostic, and therapeutic regimen. Recent advances in genomic research have identified
 many genetic variants that may be related to allergic and inflammatory disease and therapeutic response. These include variants
 involved in immune response, barrier proteins, and medication response. Current evidence also suggests that the effect of
 genetic variation often depends on the developmental stage of a child and environmental exposure such as infection or tobacco
 smoke during a specific stage. Personalized medicine is a new and exciting field with the potential to significantly improve
 medical care f...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2895632</comments>
            <pubDate>Tue, 13 Oct 2009 10:45:29 +0100</pubDate>
            <guid isPermaLink="false">2895632</guid>        </item>
        <item>
            <title>Role of mouse allergens in allergic disease</title>
            <link>http://www.medworm.com/index.php?rid=2696899&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhvj83r2722342600%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mouse allergen has long been recognized as an important cause of occupational allergy and asthma, but only recently has it
 been implicated in asthma and allergic diseases in community settings. Recent studies have established that mouse allergen
 is detectable in most US homes, with strikingly high levels in some inner cities. Inner city homes in major northeastern and
 midwestern US urban centers have levels as much as 100-fold higher than those found in other geographic regions. In addition,
 about 25% of inner city children with asthma have evidence of IgE sensitization to mouse. Several studies have shown that
 the combination of sensitization and exposure to higher levels of mouse allergen is associated with substantial asthma morbidity,
 including hospitalization...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696899</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:17 +0100</pubDate>
            <guid isPermaLink="false">2696899</guid>        </item>
        <item>
            <title>Autoimmunity in common variable immunodeficiency</title>
            <link>http://www.medworm.com/index.php?rid=2696902&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F116882681g626390%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Common variable immunodeficiency (CVID) is the most common clinically significant primary immune defect. Although the hallmark
 of CVID is hypogammaglobulinemia, the intrinsic dysregulation of the immune system leads to defective T-cell activation and
 proliferation, as well as dendritic cell and cytokine defects. Although 70% to 80% of patients have had recurrent sinopulmonary
 infections, autoimmunity and inflammatory complications are also common. The most common autoimmune conditions are immune
 thrombocytopenic purpura and hemolytic anemia, but other autoimmune complications arise, including rheumatoid arthritis, pernicious
 anemia, primary biliary cirrhosis, thyroiditis, sicca syndrome, systemic lupus, and inflammatory bowel disease. Treatment
 of autoimmunity inc...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696902</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:16 +0100</pubDate>
            <guid isPermaLink="false">2696902</guid>        </item>
        <item>
            <title>Allergens and thunderstorm asthma</title>
            <link>http://www.medworm.com/index.php?rid=2696901&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq739x63uj715jtx3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Thunderstorm-related asthma is increasingly recognized in many parts of the world. This review focuses on important advances
 in the understanding of the mechanism of the role of allergens, in particular fungal spores such as Alternaria, in asthma epidemics associated with thunderstorms. From our observations, we have proposed that the prerequisites for this
 phenomenon are as follows: 1) a sensitized, atopic, asthmatic individual; 2) prior airway hyperresponsiveness before a sudden,
 large allergen exposure; 3) a large-scale thunderstorm with cold outflow occurring at a time and location during an allergen
 season in which large numbers of asthmatics are outdoors; and 4) sudden release of large amounts of respirable allergenic
 fragments, particularly fungal spores suc...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696901</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:16 +0100</pubDate>
            <guid isPermaLink="false">2696901</guid>        </item>
        <item>
            <title>Severe asthma: What makes it so hard to manage?</title>
            <link>http://www.medworm.com/index.php?rid=2696900&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F952601670l527791%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Severe asthma presents significant management challenges. Patients can be difficult to control despite use of current standard-of-care
 therapy, including inhaled corticosteroids and long-acting β-agonists. Alternative diagnoses, noncompliance, and comorbidities
 all can influence asthma control, future risk, and response to currently available therapy. Definitions of severe asthma evaluate
 and address these confounding variables, and yet patients are still symptomatic despite aggressive, appropriate therapy. Severe
 asthma has a distinct pathophysiology including airway remodeling that contributes to the decreased effectiveness of standard
 therapy. Multiple phenotypes exist within severe asthma that likely require distinct therapeutic approaches to achieve control
 ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696900</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:16 +0100</pubDate>
            <guid isPermaLink="false">2696900</guid>        </item>
        <item>
            <title>Mast cell modulation of the immune response</title>
            <link>http://www.medworm.com/index.php?rid=2696904&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8kp0727626044241%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mast cells are present in nearly all vascularized tissues, but not the blood. They are best known for the prominent role they
 play in atopic disease. However, our current understanding of their direct and indirect roles in the immune response offers
 a more nuanced picture of both villain and hero. Although they are implicated in many inflammatory disorders, they also defend
 us from bacterial pathogens, prevent dangerous overreactions by the immune system, and even protect us from snake venom. Perhaps
 there is more to these maligned cells than we thought.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0052-zAuthors
		John J. Ryan, Virginia Commonwealth University Department of Biology P. O. Box 842012 1000 West Cary Street Richmond VA 23284-2012 USAJosephine F...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696904</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:15 +0100</pubDate>
            <guid isPermaLink="false">2696904</guid>        </item>
        <item>
            <title>Levalbuterol versus albuterol</title>
            <link>http://www.medworm.com/index.php?rid=2696903&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg268k805jt6443r4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Albuterol has been used for more than 40 years to treat acute asthma exacerbations as a racemic mixture of isomers: the active
 form, (R)-albuterol, or levalbuterol, and (S)-albuterol, classically considered inert. The single-isomer formulation, levalbuterol,
 has been synthesized recently and used therapeutically when the racemate is deemed less desirable. Basic investigations indicate
 that racemic albuterol and levalbuterol can produce effects that favor asthma remediation, including corticosteroid amplification
 and reduction of inflammatory mediators; in contrast, (S)-albuterol produces opposite effects. With inhalation of racemic
 albuterol, circulating (S)-albuterol persists 12 times longer than levalbuterol, suggesting potential for paradoxical effects
 observed...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696903</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:15 +0100</pubDate>
            <guid isPermaLink="false">2696903</guid>        </item>
        <item>
            <title>Prevention of allergic sensitization by environmental control</title>
            <link>http://www.medworm.com/index.php?rid=2696905&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F733v118p9w2t521u%2F</link>
            <description>We present published results, focusing on the most recent. There
 is great heterogeneity of results that cannot be explained by the variety of study designs alone. We propose that the next
 generation of primary prevention studies will be informed by epidemiologic studies of gene-environment interactions and will
 investigate the effects of tailor-made measures targeting individuals with specific susceptibilities who may benefit from
 specified interventions.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0053-yAuthors
		Angela Simpson, University of Manchester University Hospital of South Manchester National Health Service Foundation Trust, Second Floor, Education and Research Centre Manchester M23 9LT UKAdnan Custovic
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 15...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696905</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:11 +0100</pubDate>
            <guid isPermaLink="false">2696905</guid>        </item>
        <item>
            <title>T-regulatory cells in common variable immunodeficiency</title>
            <link>http://www.medworm.com/index.php?rid=2696910&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd2k65gt4618n1220%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0059-5Authors
		Ashwini Komarla, Washington University School of Medicine Houston TX USAJulie Y. Patel, Texas A&amp;M Health Science Center College of Medicine Houston TX USADavid P. Huston, Texas A&amp;M Health Science Center College of Medicine Houston TX USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 5 / September, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696910</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:09 +0100</pubDate>
            <guid isPermaLink="false">2696910</guid>        </item>
        <item>
            <title>Autophagy in immune cell regulation and dysregulation</title>
            <link>http://www.medworm.com/index.php?rid=2696909&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd443684273314x86%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Autophagy is an ancient pathway required for cell and tissue homeostasis and differentiation. Initially thought to be a process
 leading to cell death, autophagy is currently viewed as a beneficial catabolic process that promotes cell survival under starvation
 conditions by sequestering components of the cytoplasm, including misfolded proteins, protein aggregates, and damaged organelles,
 and targeting them for lysosome-mediated degradation. In this way, autophagy plays a role in maintaining a balance between
 degradation and recycling of cellular material. The importance of autophagy is underscored by the fact that malfunctioning
 of this pathway results in neurodegeneration, cancer, susceptibility to microbial infection, and premature aging. Autophagy
 occurs in almo...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696909</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:09 +0100</pubDate>
            <guid isPermaLink="false">2696909</guid>        </item>
        <item>
            <title>Carbohydrate moieties as important allergens</title>
            <link>http://www.medworm.com/index.php?rid=2696908&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd4611vk32l713237%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0061-yAuthors
		Robert K. Bush, University of Wisconsin-Madison Madison WI USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 5 / September, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696908</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:09 +0100</pubDate>
            <guid isPermaLink="false">2696908</guid>        </item>
        <item>
            <title>Allergen databases: Current status and perspectives</title>
            <link>http://www.medworm.com/index.php?rid=2696907&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F640n3u5673v10l91%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;An increasing number of studies on allergenic molecules have been published during the past 20 years, and the number of proteins
 reported as allergens is close to 1500 (http://www.allergome.org). Collecting, organizing, and displaying data reported in the scientific literature is becoming the major commitment of Web-based
 databases that organize this knowledge in heterogeneous ways. This heterogeneity prevents the databases from being connected
 to each other, something that has been done in several other biomedical fields. This review reports on the current status
 of allergen databases and available tools to study the allergenicity of new compounds. An analysis of what has been done by
 applying bioinformatics in other medical fields is presented. Suggestions on how...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696907</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:09 +0100</pubDate>
            <guid isPermaLink="false">2696907</guid>        </item>
        <item>
            <title>Clinical relevance of cross-reactive fungal allergens</title>
            <link>http://www.medworm.com/index.php?rid=2696906&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe3735u5382552n26%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0060-zAuthors
		Robert K. Bush, University of Wisconsin-Madison Madison WI USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 5 / September, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2696906</comments>
            <pubDate>Tue, 11 Aug 2009 00:26:09 +0100</pubDate>
            <guid isPermaLink="false">2696906</guid>        </item>
        <item>
            <title>Methotrexate for moderate to severe adult atopic eczema</title>
            <link>http://www.medworm.com/index.php?rid=2641933&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6qg7k3844u70l304%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0048-8Authors
		Allen P. Kaplan, Medical University of South Carolina Department of Medicine Charleston SC USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 4 / July, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641933</comments>
            <pubDate>Sat, 25 Jul 2009 08:59:09 +0100</pubDate>
            <guid isPermaLink="false">2641933</guid>        </item>
        <item>
            <title>The relationship of intranasal steroids to intraocular pressure</title>
            <link>http://www.medworm.com/index.php?rid=2641934&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd721616x3hm56n5q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Intranasal corticosteroids have become a gold standard in therapy for allergic rhinoconjunctivitis. A direct relationship
 between topical and systemic corticosteroids and elevated intraocular pressure (IOP) has been recognized for more than 50
 years. However, this steroid-induced response is highly variable. Glaucoma is an eye disease caused by an increase in IOP
 and results in optic nerve cell death and vision loss. Intranasal corticosteroids are absorbed systemically albeit in small
 measurable amounts. Some studies suggest a relationship between intranasal steroids and increased IOP. Large prospective studies
 to determine if there is a significant relationship between intranasal steroids and increased IOP are lacking. We review the
 current knowledge base regardi...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641934</comments>
            <pubDate>Sat, 25 Jul 2009 08:59:08 +0100</pubDate>
            <guid isPermaLink="false">2641934</guid>        </item>
        <item>
            <title>Ocular allergic disorders: Disease entities and differential diagnoses</title>
            <link>http://www.medworm.com/index.php?rid=2641936&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flj6527115tn2lh76%2F</link>
            <description>This article describes the spectrum of disorders classified as ocular allergy and outlines pathogenetic mechanisms underlying
 the various disorders. This forms the basis for a rational approach to management strategies.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0042-1Authors
		Gregg J. Berdy, Ophthalmology Associates 12990 Manchester Road, Suite 200 St. Louis MO 63131 USASusan S. Berdy
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 4 / July, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641936</comments>
            <pubDate>Sat, 25 Jul 2009 08:59:07 +0100</pubDate>
            <guid isPermaLink="false">2641936</guid>        </item>
        <item>
            <title>A 42-year-old woman with chronic rhinosinusitis and allergic mucin</title>
            <link>http://www.medworm.com/index.php?rid=2641935&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv277640734t41020%2F</link>
            <description>Content Type Journal ArticleCategory Case StudyDOI 10.1007/s11882-009-0047-9Authors
		Kimberly C. SalazarMichael R. Nelson, Walter Reed Army Medical Center Division of Allergy and Immunology 6900 Georgia Avenue NW Washington, DC 20307 USAKelly D. Stone
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 4 / July, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641935</comments>
            <pubDate>Sat, 25 Jul 2009 08:59:07 +0100</pubDate>
            <guid isPermaLink="false">2641935</guid>        </item>
        <item>
            <title>Intranasal corticosteroids: Do they improve ocular allergy?</title>
            <link>http://www.medworm.com/index.php?rid=2641937&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu762472118484412%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Allergic rhinoconjunctivitis (ARC) is a common allergic condition associated with high financial costs and decreased quality
 of life. Medical treatment options are extensive and include oral, ophthalmic, and intranasal agents. Intranasal corticosteroids
 (INS) have traditionally been used for chronic management of nasal symptoms, but have also demonstrated an impact on decreasing
 ocular symptoms of itching, tearing, and redness. Study design, including the method and timing of scoring ocular symptoms,
 is an important factor affecting whether changes in ocular symptoms are detected in INS clinical trials. INS are thought to
 exert their influence on the eye through the naso-ocular reflex, and to date their impact on ocular symptoms appears to be
 a class effect.
 
	Co...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641937</comments>
            <pubDate>Sat, 25 Jul 2009 08:59:05 +0100</pubDate>
            <guid isPermaLink="false">2641937</guid>        </item>
        <item>
            <title>Hereditary angioedema with normal C1 inhibition</title>
            <link>http://www.medworm.com/index.php?rid=2641938&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk3p5016m51137332%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Until recently, it was assumed that hereditary angioedema was a disease resulting exclusively from a genetic deficiency of
 the C1 inhibitor. In 2000, families with hereditary angioedema, normal C1 inhibitor activity, and protein in plasma were described.
 Since then, numerous patients and families with this condition have been reported. Most of the patients were women. In many
 of the affected women, oral contraceptives, hormone replacement therapy containing estrogens, and pregnancies triggered the
 clinical symptoms. In some families, mutations in the coagulation factor XII (Hageman factor) gene were detected in the affected
 persons.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0039-9Authors
		Konrad Bork, Johannes Gutenberg University Department of Dermato...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641938</comments>
            <pubDate>Sat, 25 Jul 2009 08:59:04 +0100</pubDate>
            <guid isPermaLink="false">2641938</guid>        </item>
        <item>
            <title>New concepts of hive formation in cholinergic urticaria</title>
            <link>http://www.medworm.com/index.php?rid=2641940&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjn28341631176356%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Patients with cholinergic urticaria (CU) show a number of small, short-lasting hives when their body core temperature increases,
 usually during sweating following exercise or bathing. The precise mechanism(s) of hive formation in CU has been unclear except
 for the involvement of acetylcholine. We recently reported that most CU patients show immediate-type skin responses to their
 own sweat, whereas the rest of CU patients have positive autologous serum skin tests (ASSTs). The former group produced satellite
 wheals following acetylcholine injection, whereas the latter group produced hives in conjunction with hair follicles. We propose
 two subtypes of CU: 1) a sweat-hypersensitivity type with strong hypersensitivity to autologous sweat, nonfollicular hives,
 developme...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641940</comments>
            <pubDate>Sat, 25 Jul 2009 08:59:03 +0100</pubDate>
            <guid isPermaLink="false">2641940</guid>        </item>
        <item>
            <title>Basophil responsiveness in chronic urticaria</title>
            <link>http://www.medworm.com/index.php?rid=2641939&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft1v183652m2q0322%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic urticaria is a common skin disease without an etiology in the majority of cases. The similarity of symptoms and pathology
 to allergen-induced skin reactions supports the idea that skin mast cell and blood basophil IgE receptor activation is involved;
 however, no exogenous allergen trigger has been identified. Recent evidence supports a role for blood basophils in disease
 expression. Specifically, blood basopenia is noted in active disease with the recruitment of blood basophils to skin lesional
 sites. In addition, blood basophils display altered IgE receptor-mediated degranulation that reverts in disease remission.
 In active chronic idiopathic urticaria (CIU) subjects, changes in IgE receptor-signaling molecule expression levels accompany
 the altered degra...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641939</comments>
            <pubDate>Sat, 25 Jul 2009 08:59:03 +0100</pubDate>
            <guid isPermaLink="false">2641939</guid>        </item>
        <item>
            <title>The impact of air pollutants as an adjuvant for allergic sensitization and asthma</title>
            <link>http://www.medworm.com/index.php?rid=2641941&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F232728234k5473j0%2F</link>
            <description>This article reviews the evidence supporting the fundamental role
 of air pollutants in fostering allergic inflammation of the airways, with emphasis on the molecular and genetic pathways that
 link ambient particulate matter (PM) exposure to the induction of proinflammatory changes and proallergic effects in the respiratory
 tract. We propose that the link between PM exposure and proallergic effects involves organic PM components that generate oxygen
 radicals capable of perturbing the redox equilibrium mucosal immune cells.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0046-xAuthors
		Loida VieraKarin ChenAndre NelMaria Garcia Lloret, University of California Division of Pediatric Allergy, Immunology and Rheumatology, Department of Pediatrics, and the Asthma and Allergic Diseases...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641941</comments>
            <pubDate>Sat, 25 Jul 2009 08:59:01 +0100</pubDate>
            <guid isPermaLink="false">2641941</guid>        </item>
        <item>
            <title>Abnormal skin barrier in the etiopathogenesis of atopic dermatitis</title>
            <link>http://www.medworm.com/index.php?rid=2641942&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1p51237000w86256%2F</link>
            <description>This article reviews emerging evidence that the inflammation in AD results from inherited and acquired insults
 to the barrier, as well as the therapeutic implications of this new paradigm.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0037-yAuthors
		Peter M. Elias, VA Medical Center Dermatology Service (190) 4150 Clement Street San Francisco CA 94121 USAMatthias Schmuth
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 4 / July, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641942</comments>
            <pubDate>Sat, 25 Jul 2009 08:58:58 +0100</pubDate>
            <guid isPermaLink="false">2641942</guid>        </item>
        <item>
            <title>Orbital myositis: Diagnosis and management</title>
            <link>http://www.medworm.com/index.php?rid=2641943&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq11x050161w02817%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Orbital myositis is an inflammatory process that primarily involves the extraocular muscles and most commonly affects young
 adults in the third decade of life, with a female predilection. Clinical characteristics of orbital myositis include orbital
 and periorbital pain, ocular movement impairment, diplopia, proptosis, swollen eyelids, and conjunctival hyperemia. The most
 common presentation is acute and unilateral, which initially responds to systemic corticosteroid therapy. However, chronic
 and recurrent cases may involve both orbits. Many inflammatory, vascular, neoplastic, and infectious conditions that affect
 the extraocular muscles and other orbital tissue can mimic orbital myositis. The most important differential diagnoses include
 thyroid-related eye diseas...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641943</comments>
            <pubDate>Sat, 25 Jul 2009 08:58:57 +0100</pubDate>
            <guid isPermaLink="false">2641943</guid>        </item>
        <item>
            <title>Pathogenesis of atopic dermatitis: New developments</title>
            <link>http://www.medworm.com/index.php?rid=2641944&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F81h551837738n658%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Atopic dermatitis (AD) is a paradigmatic skin disease in which multiple gene-gene and gene-environment interactions play a
 pivotal role. Although the complex pathophysiologic network of AD explains the large spectrum of risk and trigger factors,
 it is far from being comprehensively understood. Hence, genetic modifications underlying the dysfunction of the epidermal
 skin barrier as well as the close interaction of innate and adaptive immune mechanisms were the focus of intensive research
 studies. This review aims to summarize the most recent findings in this field.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0041-2Authors
		Thomas Bieber, Rheinische Friedrich-Wilhelms-University Bonn Department of Dermatology and Allergy Sigmund-Freud-Str. 25 D-53105 Bonn G...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641944</comments>
            <pubDate>Sat, 25 Jul 2009 08:58:56 +0100</pubDate>
            <guid isPermaLink="false">2641944</guid>        </item>
        <item>
            <title>Mycophenolate mofetil for severe childhood atopic dermatitis</title>
            <link>http://www.medworm.com/index.php?rid=2641945&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F040t024627334062%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0049-7Authors
		Allen P. Kaplan, Medical University of South Carolina Department of Medicine Charleston SC USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 4 / July, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641945</comments>
            <pubDate>Sat, 25 Jul 2009 08:58:55 +0100</pubDate>
            <guid isPermaLink="false">2641945</guid>        </item>
        <item>
            <title>Building better mouse models of asthma</title>
            <link>http://www.medworm.com/index.php?rid=2448239&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy39464988v2k5v85%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Allergic asthma is a complex disease that has been modeled extensively in small rodents. Airway eosinophilia and changes in
 lung function have been documented using a variety of protocols. However, recent efforts have improved these models by trying
 to replicate the structural remodeling that occurs in the lung as a consequence of chronic allergen-driven inflammation. This
 review documents the recent developments in protocols and systems designed to examine pathways leading to allergen-induced
 airway remodeling.
 
	Content Type Journal ArticleDOI 10.1007/s11882-007-0077-0Authors
		Clare M. Lloyd, Imperial College Leukocyte Biology Section, National Heart and Lung Institute, Faculty of Medicine London SW7 2AZ England
	

	
		Journal Current Allergy and Asthma ReportsO...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448239</comments>
            <pubDate>Sat, 30 May 2009 08:10:27 +0100</pubDate>
            <guid isPermaLink="false">2448239</guid>        </item>
        <item>
            <title>The potential of Mycobacterium to protect against allergy and asthma</title>
            <link>http://www.medworm.com/index.php?rid=2448240&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff8176hm3441677p1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The increase in the global incidence of atopic disease and asthma during the past few decades has been ascribed to environmental
 factors, including the reduction in exposure to serious infections. The hypothetical framework to explain the inverse relationship
 between infections and atopic disease and asthma has been called the “hygiene hypothesis.” Animal and experimental models
 have identified Mycobacteria as important potential candidates in the hygiene hypothesis by demonstrating that exposure to Mycobacteria or mycobacterial proteins led to subsequent reduction in different atopic manifestations. Although there are epidemiological
 studies in support, they have not always been consistent. In this review we appraise epidemiologic evidence on the inverse
 relat...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448240</comments>
            <pubDate>Sat, 30 May 2009 08:10:25 +0100</pubDate>
            <guid isPermaLink="false">2448240</guid>        </item>
        <item>
            <title>Progress in surgical management of chronic rhinosinusitis and nasal polyposis</title>
            <link>http://www.medworm.com/index.php?rid=2448241&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn10r420tw344287l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Endoscopic sinus surgery (ESS) remains the treatment (CRS) with or without nasal polyposis (NP). ESS has undergone review,
 reassessment, and substantial refinement. Several advances (eg, powered instrumentation, image guidance, adjunctive intraoperative
 procedures) have expanded the scope of cases amenable to ESS, decreased operative time and intraoperative blood loss, and
 improved safety. Procoagulant nasal/sinus packing and refinements of technique have decreased the need for postoperative removal
 of packing, thus decreasing morbidity. Methods to reduce synechia formation (ie, mitomycin-c) have been explored, with mixed
 results. Novel methods of sinusotomy (eg, balloon catheter dilatation of the sinus ostia) have had limited but interesting
 short-term results. W...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448241</comments>
            <pubDate>Sat, 30 May 2009 08:10:24 +0100</pubDate>
            <guid isPermaLink="false">2448241</guid>        </item>
        <item>
            <title>The role of antileukotriene drugs in management of rhinitis and rhinosinusitis</title>
            <link>http://www.medworm.com/index.php?rid=2448242&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe529162441w418gk%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Antileukotriene drugs have been studied for more than 15 years. In his review we examine the role of leukotrienes in rhinitis
 and rhinosinusitis, and explore the clinical literature supporting the use of antileukotriene agents in these diseases. Although
 these medications clearly are efficacious in rhinitis, it is unclear where in the armamentarium they should be used. The evidence
 for use in sinusitis has not been well studied except in sinusitis-associated aspirin-exacerbated respiratory disease. In
 this circumstance there is information that allows use of antileukotriene agents to be considered effi cacious. We provide
 our rationale for use and await future clinical studies to answer this important question.
 
	Content Type Journal ArticleDOI 10.1007/s11882-007-...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448242</comments>
            <pubDate>Sat, 30 May 2009 08:10:23 +0100</pubDate>
            <guid isPermaLink="false">2448242</guid>        </item>
        <item>
            <title>Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps</title>
            <link>http://www.medworm.com/index.php?rid=2448243&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw60433327r301n72%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic rhinosinusitis (CRS) is presently classified into two subgroups: CRS without and CRS with nasal polyps. A variety
 of inflammatory mediators, including cytokines and chemokines, as well as adhesion molecules and matrix metalloproteinases,
 are upregulated in both subgroups of CRS; remodeling is also observed in both. However, there are also characteristic differences.
 Whereas CRS without nasal polyps has more neutrophilic infiltration, in CRS with nasal polyps (especially when associated
 with allergy/asthma) eosinophil infiltration is strikingly increased. Although several features of remodeling (eg, squamous
 metaplasia, basement membrane thickening, collagen deposition, hyperplasia of mucous glands, and goblet cells) are features
 seen in both subgroups of C...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448243</comments>
            <pubDate>Sat, 30 May 2009 08:10:22 +0100</pubDate>
            <guid isPermaLink="false">2448243</guid>        </item>
        <item>
            <title>Laryngopharyngeal reflux and chronic sinusitis</title>
            <link>http://www.medworm.com/index.php?rid=2448244&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd3qk34u68756pp43%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In patients with chronic and recurrent sinusitis, laryngopharyngeal reflux disease may play a significant role. Laryngopharyngeal
 reflux disease differs from gastroesophageal reflux disease in the extent of reflux (into the hypopharynx and above) as well
 as timing (occurring more often when the patient is upright). Most patients are unaware of the extent of their symptoms, and
 diagnostic tools such as pH probe, multichannel intraluminal impedance, and manometry are required for adequate diagnosis.
 Although therapy with lifestyle modification and acid-suppressive agents may improve reflux in the majority of patients, for
 many with persistent symptoms, endoscopic or surgical intervention is required to reduce reflux successfully.
 
	Content Type Journal ArticleDOI 10...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448244</comments>
            <pubDate>Sat, 30 May 2009 08:10:21 +0100</pubDate>
            <guid isPermaLink="false">2448244</guid>        </item>
        <item>
            <title>Food allergy and autism spectrum disorders: Is there a link?</title>
            <link>http://www.medworm.com/index.php?rid=2342311&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw227nl671231412q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Gastrointestinal (GI) symptoms are common comorbidities in children with autism spectrum disorders (ASDs). Parents often attribute
 these GI symptoms to food allergy (FA), although an evaluation for IgE-mediated FA is often unrevealing. Our previous studies
 indicated a high prevalence of non-IgE-mediated FA in young children with ASDs. Therefore, non-IgE-mediated FA may account
 for some but not all GI symptoms observed in children with ASDs. This raises the question of what treatment measures are applicable
 to ASD children with GI symptoms. A wide variety of dietary supplements and dietary intervention measures for ASD children
 have been promoted by medical professionals practicing complementary and alternative medicine despite the lack of rigorous
 scientific valid...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2342311</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:11 +0100</pubDate>
            <guid isPermaLink="false">2342311</guid>        </item>
        <item>
            <title>Fatal anaphylaxis to foods: Epidemiology, recognition, and prevention</title>
            <link>http://www.medworm.com/index.php?rid=2342312&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm070g108010343qj%2F</link>
            <description>This article briefly reviews the epidemiology of fatal anaphylactic reactions to foods, discusses
 factors that may aid in identifying individuals at higher risk, emphasizes important aspects of patient education and prevention,
 and touches on the psychological impact of having a family member with food allergy.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0027-0Authors
		Dan Atkins, National Jewish Health 1400 Jackson Street J301 Denver CO 80206 USAS. Allan Bock
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 3 / May, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2342312</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:10 +0100</pubDate>
            <guid isPermaLink="false">2342312</guid>        </item>
        <item>
            <title>Endoscopic sinus surgery and asthma outcomes</title>
            <link>http://www.medworm.com/index.php?rid=2342313&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F58tp1x728763g487%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0026-1Authors
		Marek L. Kowalski
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 3 / May, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2342313</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:09 +0100</pubDate>
            <guid isPermaLink="false">2342313</guid>        </item>
        <item>
            <title>Maxillary sinusitis of odontogenic origin</title>
            <link>http://www.medworm.com/index.php?rid=2342315&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F43550q40847r4774%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Odontogenic etiology accounts for 10% to 12% of cases of maxillary sinusitis. Although uncommon, direct spread of dental infections
 into the maxillary sinus is possible due to the close relationship of the maxillary posterior teeth to the maxillary sinus.
 If a periapical dental infection or dental/oral surgery procedure violates the schneiderian membrane integrity, infection
 will likely spread into the sinus, leading to sinusitis. An odontogenic source should be considered in individuals with symptoms
 of maxillary sinusitis and a history of dental or jaw pain; dental infection; oral, periodontal, or endodontic surgery; and
 in those people resistant to conventional sinusitis therapy. An odontogenic infection is a polymicrobial aerobic-anaerobic
 infection, with anae...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2342315</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:08 +0100</pubDate>
            <guid isPermaLink="false">2342315</guid>        </item>
        <item>
            <title>Diagnosis and management of acute rhinosinusitis in children</title>
            <link>http://www.medworm.com/index.php?rid=2342314&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcw87uxr460m36257%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Rhinosinusitis is a common disease in children that is often overlooked. The clinical symptoms of acute rhinosinusitis are
 nasal blockage or congestion, nasal discharge or postnasal drip (often mucopurulent), facial pain, headache, and reduction
 in/loss of smell. Direct vision by nasal fibroendoscopy may aid the diagnosis. Regarding imaging criteria, recent consensus
 documents state that plain sinus x-rays are of limited utility, and CT remains the technique of choice, particularly in children
 with complications or very persistent or recurrent infections that are unresponsive to medical management. Antibiotics are
 the primary form of medical treatment for acute bacterial rhinosinusitis, but they should be used when acute bacterial rhinosinusitis
 presents as persis...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2342314</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:08 +0100</pubDate>
            <guid isPermaLink="false">2342314</guid>        </item>
        <item>
            <title>Antifungal treatment and chronic rhinosinusitis</title>
            <link>http://www.medworm.com/index.php?rid=2342316&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk64027j13163552q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic rhinosinusitis (CRS) is an inflammatory disease with a multifactorial etiology. Antifungal therapy is not routinely
 used to treat it. However, evidence implicating fungi in some forms of CRS recently has been published. Controversy exists
 as to whether fungi identified in sinonasal cultures are always pathogenic. Immunologic evidence supporting the role of fungi
 in the pathogenesis of CRS is also debated. Topical antifungal therapy is more widely used than oral therapy, with amphotericin
 B irrigation being the most common. Although some studies show benefit from this irrigation, others refute the efficacy. Although
 oral antifungal agents are used uncommonly, itraconazole is the most commonly used drug. The efficacy of oral itraconazole
 in CRS has never bee...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2342316</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:07 +0100</pubDate>
            <guid isPermaLink="false">2342316</guid>        </item>
        <item>
            <title>Chronic rhinosinusitis with and without nasal polyps: What is the difference?</title>
            <link>http://www.medworm.com/index.php?rid=2342317&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjp2l2x6w22642j67%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic rhinosinusitis is a heterogeneous group of chronic sinus diseases that may consist of clearly different disease entities.
 Further investigation of the pathomechanisms of chronic rhinosinusitis and the introduction of appropriate disease markers
 have recently facilitated disease classification. Evaluation of inflammatory cell profiles, the differentiation of T-effector
 cells, characterization of remodeling processes such as fibrosis or edema formation, and innate or adaptive immunity products
 such as Toll-like receptors and immunoglobulins all provide tools to identify distinct disease entities within the group of
 chronic sinus diseases. This disease differentiation will not only increase our knowledge of the pathophysiology of sinusitis
 but may lead to new...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2342317</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:06 +0100</pubDate>
            <guid isPermaLink="false">2342317</guid>        </item>
        <item>
            <title>The role of innate immunity in the pathogenesis of chronic rhinosinusitis</title>
            <link>http://www.medworm.com/index.php?rid=2342319&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F235063h04k426527%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory condition with a multifactorial basis. Infectious triggers of
 CRS have been proposed, but demonstration remains elusive. Evolving research suggests that abnormal host mucosal immune responses,
 rather than specific pathogens themselves, may underlie the chronic inflammatory state. Despite constant contact with airborne
 particulates and microorganisms, the sinonasal epithelium maintains mucosal homeostasis through innate and adaptive immune
 mechanisms that eliminate potential threats. Innate immunity encompasses a broad collection of constitutive and inducible
 processes that can be nonspecific or pathogen directed. Some innate immune pathways are closely intertwined with tissue growth
 and repair. The persi...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2342319</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:05 +0100</pubDate>
            <guid isPermaLink="false">2342319</guid>        </item>
        <item>
            <title>Oral immunotherapy for food allergy</title>
            <link>http://www.medworm.com/index.php?rid=2342318&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa46r324727t03983%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Food allergy is an increasingly prevalent disorder with potentially life-threatening complications that requires life-altering
 changes in dietary habits and psychosocial interactions. The standard of care presently includes strict dietary elimination
 of the implicated allergen and ready access to injectable epinephrine; however, no active, definitive therapeutic options
 exist for food-allergic patients. Although the detailed immunologic mechanisms underlying the development of food allergy
 are still being fully defined, food allergy appears to be the direct result of a breakdown in oral tolerance. Thus, current
 therapeutic approaches to food allergy are focused on modulating the immunologic response to food proteins to promote induction
 of oral tolerance. In this ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2342318</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:05 +0100</pubDate>
            <guid isPermaLink="false">2342318</guid>        </item>
        <item>
            <title>Antimicrobial therapy in chronic rhinosinusitis</title>
            <link>http://www.medworm.com/index.php?rid=2342320&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F950q36366170h8h7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Antimicrobial therapy has been a mainstay of treatment for chronic rhinosinusitis (CRS). The roles of bacterial and fungal
 infection in the primary pathogenesis of CRS recently have been called into question. Although many different bacteria and
 fungi can be isolated from CRS patients, antimicrobial treatment directed at their eradication has met with mixed clinical
 results. Overall, macrolide antibiotics hold the most promise before surgery. Topical antibiotics are safe, efficient, and
 effective for treating acute bacterial exacerbations of CRS after endoscopic sinus surgery and may prevent the development
 of subsequent bacterial resistance. Topical treatment of CRS with antifungal agents both before and after sinus surgery is
 of limited benefit and should not be...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2342320</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:04 +0100</pubDate>
            <guid isPermaLink="false">2342320</guid>        </item>
        <item>
            <title>Diagnostic and therapeutic value of airway challenges in asthma</title>
            <link>http://www.medworm.com/index.php?rid=2342321&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F13w9563271633577%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Airway challenges are of value in the assessment of asthma. Direct challenges (histamine and methacholine) are highly sensitive
 for clinically current symptomatic asthma and particularly useful to exclude current asthma when they are negative. Indirect
 challenges (exercise, eucapnic voluntary hyperventilation, adenosine monophosphate, hypertonic saline, mannitol) are more
 specific but very insensitive for clinical asthma. They are of particular value to confirm asthma and to differentiate asthma
 from other airway diseases, such as chronic airflow limitation. The indirect stimuli are the challenges of choice for evaluating
 exercise-induced bronchoconstriction.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0036-zAuthors
		Donald W. Cockcroft, Royal University...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2342321</comments>
            <pubDate>Sun, 05 Apr 2009 13:13:03 +0100</pubDate>
            <guid isPermaLink="false">2342321</guid>        </item>
        <item>
            <title>Guaifenesin in rhinitis</title>
            <link>http://www.medworm.com/index.php?rid=2182684&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw490268167v87110%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mucus in the airways is a complex mixture of water, lipids, glycoproteins, sugars, and electrolytes that serves as a lubricant
 for the epithelium. The efficient flow of respiratory mucus is a first level of immune defense that requires an appropriate
 viscosity and elasticity for optimal barrier and ciliary functions. Thickening and drying of airway mucus by respiratory tract
 infections, allergies, and drugs can impair evacuation. Tenacious, bothersome mucus is an annoying and frequent symptom of
 rhinitis that is difficult to manage. Common remedies include adequate hydration through fluid intake and nasal washes. The
 use of mucoactive agents is controversial due to limited data and equivocal efficacy in available studies. Nonetheless, some
 patients benefit. This r...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182684</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:56 +0100</pubDate>
            <guid isPermaLink="false">2182684</guid>        </item>
        <item>
            <title>Updated practice parameters for the diagnosis and management of rhinitis</title>
            <link>http://www.medworm.com/index.php?rid=2182685&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd7502173525824l5%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0014-5Authors
		James N. Baraniuk
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 2 / March, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182685</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:54 +0100</pubDate>
            <guid isPermaLink="false">2182685</guid>        </item>
        <item>
            <title>Update on prescription and over-the-counter histamine inverse agonists in rhinitis therapy</title>
            <link>http://www.medworm.com/index.php?rid=2182688&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk660072663227856%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Allergic rhinitis (AR) is associated with histamine-mediated physiologic events. The currently used histamine antagonists
 are all inverse agonists that bind and inactivate histamine H1 receptors. Second- generation antihistamines are much more
 H1-receptor selective with less central nervous system penetration than first-generation agents. Antihistamines typically
 are more effective in seasonal than perennial AR and do not demonstrate significant relief of nasal congestion. The recent
 availability of some second-generation antihistamines as over-the-counter products clearly places them as the preferred first-line
 treatment for mild to moderate AR based on safety when compared with first-generation over-the-counter antihistamines. The
 remaining prescription-only sec...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182688</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:52 +0100</pubDate>
            <guid isPermaLink="false">2182688</guid>        </item>
        <item>
            <title>The placebo effect: Plugging the nostrils of unmet needs</title>
            <link>http://www.medworm.com/index.php?rid=2182687&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4277661px86u9270%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Many common treatments for rhinitis symptoms are inadequate or ineffective. This may be in part because the drug does not
 address the pathologically altered mechanism of the rhinopathy. Objective measures may not detect treatment effects, or the
 treatment end points may be only subjective in nature. In many cases, these issues have not arisen because of potent placebo
 effects. Understanding the psychological, pharmacologic, and physiologic components of placebos is important for separating
 true treatment effects from those of the excipients in the vehicle. Separating the wasteful and potentially harmful effects
 of those excipients from the harmless and often partially beneficial effects on temporary symptom control is an important
 issue in clinical pharmacology th...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182687</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:52 +0100</pubDate>
            <guid isPermaLink="false">2182687</guid>        </item>
        <item>
            <title>Aspirin sensitivity and desensitization for asthma and sinusitis</title>
            <link>http://www.medworm.com/index.php?rid=2182686&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc6l3m8321r522145%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;NSAIDs—including aspirin (ASA)—that inhibit cyclooxygenase (COX)-1 induce nonallergic hypersensitivity reactions consisting
 of attacks of rhinitis and asthma. Such reactions occur exclusively in a subset of asthmatic patients who also have underlying
 nasal polyps and chronic hyperplastic eosinophilic sinusitis. We now refer to their underlying inflammatory disease of the
 entire respiratory tract as aspirin-exacerbated respiratory disease. This review focuses on descriptions of these patients; methods available to diagnose ASA-exacerbated respiratory disease;
 the unique ability of all NSAIDs that inhibit COX-1 to cross-react with ASA; lack of cross-reactivity with selective COX-2
 inhibitors; an update on pathogenesis; and current thoughts about treatment, includ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182686</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:52 +0100</pubDate>
            <guid isPermaLink="false">2182686</guid>        </item>
        <item>
            <title>Air pollution and allergic disease</title>
            <link>http://www.medworm.com/index.php?rid=2182690&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj25218172463n3n2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Over the past several decades, there has been increased awareness of the health effects of air pollution and much debate regarding
 the role of global warming. The prevalence of asthma and allergic disease has risen in industrialized countries, and most
 epidemiologic studies focus on possible causalities between air pollution and these conditions. This review examines salient
 articles and summarizes findings important to the interaction between allergies and air pollution, specifically volatile organic
 compounds, global warming, particulate pollutants, atopic risk, indoor air pollution, and prenatal exposure. Further work
 is necessary to determine whether patients predisposed to developing allergic disease may be more susceptible to the health
 effects of air pollut...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182690</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:51 +0100</pubDate>
            <guid isPermaLink="false">2182690</guid>        </item>
        <item>
            <title>Acetaminophen use: A risk for asthma?</title>
            <link>http://www.medworm.com/index.php?rid=2182689&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3877q3v171262514%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A growing number of studies show that regular use of acetaminophen (paracetamol) carries a dose-dependent risk of developing
 allergies in general and asthma in particular and of worsening other respiratory diseases and lung function. The most disturbing
 finding has come from the population-based Avon Longitudinal Study of Parents and Children, in which use of paracetamol—but
 not aspirin—in late pregnancy was positively associated with asthma when comparing children whose mothers took paracetamol
 “sometimes” and “most days/daily” with those whose mothers never took it. Assuming a causal relationship, the percentage of
 asthma attributable to paracetamol use in late pregnancy was 7%. In this review, we present data from the most important studies
 publishe...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182689</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:51 +0100</pubDate>
            <guid isPermaLink="false">2182689</guid>        </item>
        <item>
            <title>The mold conundrum in chronic hyperplastic sinusitis</title>
            <link>http://www.medworm.com/index.php?rid=2182691&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr64x17j463341v06%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The role of fungi in chronic rhinosinusitis (CRS) is not clear. Fungi can be detected in the nose and paranasal sinuses of
 virtually all CRS patients; however, they also appear to be present in healthy controls. Various theories attempt to explain
 the mechanisms by which fungi can exert an effect on sinus mucosa in susceptible individuals. Further studies are necessary
 to clarify the role of fungi in CRS, which fungal organisms (if any) are pathogenic, and what exactly characterizes the immunologic
 response to fungi that may result in the development of disease. However, in the absence of convincing immunologic data and
 evidence of clinical improvement of CRS after antifungal therapy, the case against the fungus remains unproven.
 
	Content Type Journal ArticleDOI ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182691</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:50 +0100</pubDate>
            <guid isPermaLink="false">2182691</guid>        </item>
        <item>
            <title>Role of nasal allergy in chronic secretory otitis media</title>
            <link>http://www.medworm.com/index.php?rid=2182692&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F98u6748q554n2366%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Nasal allergy seems to be one of the important causes of chronic secretory otitis media (SOM) in children and adults. Chronic
 SOM is unequivocally related to disturbed function of the eustachian tube, which facilitates communication of the middle ear
 with the nasopharynx, nasal cavity, and indirectly with paranasal sinuses. The most serious consequences of chronic SOM are
 decreased elasticity of the tympanic membrane and hearing impairment. Allergic reactions in the nasal mucosa leading to release
 of various mediators result in development of three types of nasal response characterized predominantly by nasal obstruction.
 Eustachian tube functions can be affected directly by the mediators released in the nasal mucosa or indirectly by the nasal
 obstruction. Nasal ch...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182692</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:48 +0100</pubDate>
            <guid isPermaLink="false">2182692</guid>        </item>
        <item>
            <title>Assessing nasal symptom control</title>
            <link>http://www.medworm.com/index.php?rid=2182693&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq420375u47102601%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Rhinitis is a common chronic disease that significantly impacts morbidity, health care costs, work and school productivity,
 and quality of life. Therefore, appropriate management is paramount to help to reduce the burden of disease. In current clinical
 practice, there are no validated instruments widely used to assess rhinitis control. In this review, we describe the tools
 available for assessing nasal symptom control in patients with rhinitis. The recently developed Allergic Rhinitis Control
 Assessment is a promising tool with demonstrated validity, reliability, and ease of use. Health care providers are encouraged
 to use the rhinitis-specific tools and incorporate other objective measures, such as rhinoscopy and rhinometric techniques,
 when evaluating patients w...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182693</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:46 +0100</pubDate>
            <guid isPermaLink="false">2182693</guid>        </item>
        <item>
            <title>Irreversible airway obstruction in asthma</title>
            <link>http://www.medworm.com/index.php?rid=2182695&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp3qn87u6182u2342%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Asthma is generally characterized by fully reversible airway obstruction. However, a significant proportion of asthma patients
 demonstrate an incomplete reversibility of airway obstruction (IRAO) despite optimal treatment and the absence of a significant
 smoking history. Such partially irreversible airway obstruction may be due to residual airway inflammation, particularly of
 the eosinophilic type, and structural changes. Risks factors for IRAO include reduced pulmonary function early in life, frequent
 exacerbations, smoking, continuing exposure to a sensitizing agent, and adult-onset asthma. IRAO is associated with increased
 disease severity and increased asthma-related morbidity and mortality. Optimal asthma control, including prevention of asthma
 exacerbations,...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182695</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:45 +0100</pubDate>
            <guid isPermaLink="false">2182695</guid>        </item>
        <item>
            <title>Allergic rhinoconjunctivitis: Complementary treatments for the 21st century</title>
            <link>http://www.medworm.com/index.php?rid=2182694&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy5m2w35h94570j60%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Even in the 21st century, some seeds of tradition remain firmly grounded regardless of the technological advancements of humankind.
 One such “tradition” involves using unconventional means—including mental healing, herbal formulas, and healing hand therapies
 such as acupuncture—to treat chronic illnesses. Although mental healing is unproven and energy therapy is not completely understood,
 acupuncture, herbal therapy, and sublingual immunotherapy have been described more extensively with mixed results that lack
 consistency and high-quality scientific data. Researchers are working to modernize these traditional therapies in the treatment
 of allergic disorders and using advanced technology to alter what some call “the earth’s natural healing power” in ho...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182694</comments>
            <pubDate>Wed, 11 Feb 2009 07:20:45 +0100</pubDate>
            <guid isPermaLink="false">2182694</guid>        </item>
        <item>
            <title>Exhaled nitric oxide in pediatric asthma</title>
            <link>http://www.medworm.com/index.php?rid=2033296&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk21764r0g53g0418%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Exhaled nitric oxide can now be measured in a clinical setting as a noninvasive, reproducible, facile, point-of-service test
 to measure airway inflammation, a central component of asthma that had not been assessed previously. An excellent surrogate
 marker of steroid-responsive eosinophilic airway inflammation, it serves to identify steroid-sensitive asthmatic patients
 and enables clinical monitoring of the response to steroid therapy and titration of the dose. Standardization of methodology
 and technological advances, such as the recent availability of handheld analyzers, individualized patient cards to store serial
 test measurements, and the assignment of coding procedural terminology, make this a necessary adjunct to clinical and functional
 assessment of airway ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033296</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:57 +0100</pubDate>
            <guid isPermaLink="false">2033296</guid>        </item>
        <item>
            <title>Genome-wide association studies in the genetics of asthma</title>
            <link>http://www.medworm.com/index.php?rid=2033295&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcl7p8735113jj711%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The field of asthma genetics has progressed rapidly over the past decade, implicating many genes and variants in the etiology
 of this complex disease. However, many of these factors have failed to replicate consistently, indicating a high false-positive
 rate and/or insufficient power for the detection of small effects. Technological limitations also have restricted the potential
 to detect novel mechanisms, fostering a dependence on existing knowledge. Since its inception almost 4 years ago, genome-wide
 association (GWA) has transformed genetic studies of multifactorial traits and yielded unprecedented insights into mechanisms
 of causation. Asthma is at the forefront of this revolution, as it uses GWA to map not only genetic determinants of clinical
 status but also...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033295</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:57 +0100</pubDate>
            <guid isPermaLink="false">2033295</guid>        </item>
        <item>
            <title>The pharmacogenetics of asthma treatment</title>
            <link>http://www.medworm.com/index.php?rid=2033299&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh2v75104336q3151%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The treatment response to each of the three major classes of asthma medications—β agonists, leukotriene modifiers, and inhaled
 corticosteroids—demonstrates substantial interindividual variability. Evidence indicates that this variability is mediated,
 at least in part, by genetic factors. Pharmacogenetics is the study of the role of heritable factors in the response to pharmacologic
 therapy. The goal of pharmacogenetics is “predictive medicine,” whereby a genetic profile, combined with clinical characteristics,
 can be used to predict response to medications a priori, allowing for maximal therapeutic response while minimizing side effects. In this review, we discuss the rationale behind
 conducting asthma pharmacogenetics studies, provide an overview of asthm...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033299</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:56 +0100</pubDate>
            <guid isPermaLink="false">2033299</guid>        </item>
        <item>
            <title>Role of leukotrienes in exercise-induced bronchoconstriction</title>
            <link>http://www.medworm.com/index.php?rid=2033298&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft675378h15432023%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Exercise-induced bronchoconstriction (EIB) refers to acute airflow obstruction that is triggered by a period of physical exertion.
 EIB occurs mainly in individuals with other features of asthma but is especially prominent in a subset of asthmatics with
 pronounced indirect airway hyperresponsiveness. Leukotrienes (LTs) play a critical role in the pathophysiology of EIB. Asthmatics
 who are susceptible to EIB have increased levels of cysteinyl LTs (cysLTs [ie, LTs C4, D4, and E4]) in induced sputum and exhaled breath condensate. Exercise challenge in individuals susceptible to this disorder initiates
 the sustained increase in cysLTs in the airways and an increase in the ratio of cysLTs to prostaglandin E2. The effects of cysLTs leading to secreted mucin release and smo...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033298</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:56 +0100</pubDate>
            <guid isPermaLink="false">2033298</guid>        </item>
        <item>
            <title>Gastrointestinal eosinophil-mediated disorders and their treatment</title>
            <link>http://www.medworm.com/index.php?rid=2033297&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F327165525q75l171%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Eosinophilic esophagitis has become a diagnosis familiar to allergists and immunologists who treat pediatric patients presenting
 with complaints of recurrent vomiting, feeding difficulty, abdominal pain, dysphagia, and food impaction. Over the past 3
 years, published research has addressed several clinically important issues, including incidence among special patient populations,
 adult patients and familial cases, diagnostic features, natural history and complications, therapies with topical steroids,
 and pathogenesis with distinct genetic markers of the disorder.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0004-7Authors
		Amal Assa’ad, Cincinnati Children’s Hospital Medical Center Division of Allergy and Immunology 3333 Burnet Avenue Cincinnati OH 452...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033297</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:56 +0100</pubDate>
            <guid isPermaLink="false">2033297</guid>        </item>
        <item>
            <title>General anesthetic allergy testing</title>
            <link>http://www.medworm.com/index.php?rid=2033303&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp01g16783hp52748%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Anaphylaxis in the setting of general anesthesia is a rare but potentially lethal event. The investigation of severe reactions
 is important for confirming the clinical diagnosis and identifying likely causative agents and safe agents that may be used
 in the future. Many comprehensive reports have described the testing protocol of individual specialized units, whereas there
 has been no standardization of testing techniques or formal assessment of these tests’ diagnostic accuracy. We review the
 literature with reference to the recently published standards for reporting of diagnostic accuracy (STARD) and make recommendations
 for future studies of diagnostic accuracy in the field.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0008-3Authors
		Karl E. Bleasel, ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033303</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:55 +0100</pubDate>
            <guid isPermaLink="false">2033303</guid>        </item>
        <item>
            <title>Characteristics of food-allergic patients placing them at risk for a fatal anaphylactic episode</title>
            <link>http://www.medworm.com/index.php?rid=2033302&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8kt184563q212834%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Food allergy is a growing public health and food safety concern. Twelve million Americans—4% of the population—suffer from
 the disease, and the prevalence is increasing. There is no cure for food allergy; strict avoidance is the only way to prevent
 a reaction. Food allergy is a major cause of anaphylaxis, a severe, potentially life-threatening allergic reaction that results
 in an estimated 30,000 emergency department visits and 100 to 150 deaths annually. Factors that place food-allergic patients
 at greater risk for a fatal anaphylactic episode include asthma; being a teen or young adult; peanut, tree nut, and seafood
 allergy; not carrying epinephrine; restaurant food; spending time in schools and child care settings; and lack of information
 from health care p...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033302</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:55 +0100</pubDate>
            <guid isPermaLink="false">2033302</guid>        </item>
        <item>
            <title>Fixed drug eruption: A prototypic disorder mediated by effector memory T cells</title>
            <link>http://www.medworm.com/index.php?rid=2033301&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq7q0423071684042%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Effector memory T cells are uniquely specialized to mediate protective immunity. However, their excessive activation may result
 in the development of organ-specific inflammatory diseases, which have not been extensively studied. Fixed drug eruption (FDE),
 a localized variant of drug-induced dermatoses characterized by relapse in the same location, is a prototypic disorder mediated
 by excessive activation of effector memory T cells, which are resident in the lesional epidermis. A variety of clinical and
 pathologic features uniquely observed in FDE lesions can be explained by the presence of CD8+ intraepidermal T cells with the effector memory phenotype in the FDE lesion. This review focuses on how these T cells are
 generated, retained in the epidermis, and activated...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033301</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:55 +0100</pubDate>
            <guid isPermaLink="false">2033301</guid>        </item>
        <item>
            <title>Is this a death knell for anti-interleukin-5 therapy in asthma?</title>
            <link>http://www.medworm.com/index.php?rid=2033300&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F95l20v176607r57x%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-009-0006-5Authors
		Phillip Lieberman
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 9
	
		Journal Issue Volume 9, Number 1 / January, 2009 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033300</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:55 +0100</pubDate>
            <guid isPermaLink="false">2033300</guid>        </item>
        <item>
            <title>Vitamin D, respiratory infections, and asthma</title>
            <link>http://www.medworm.com/index.php?rid=2033306&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F605354423r218140%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Over the past decade, interest has grown in the role of vitamin D in many nonskeletal medical conditions, including respiratory
 infection. Emerging evidence indicates that vitamin D-mediated innate immunity, particularly through enhanced expression of
 the human cathelicidin antimicrobial peptide (hCAP-18), is important in host defenses against respiratory tract pathogens.
 Observational studies suggest that vitamin D deficiency increases risk of respiratory infections. This increased risk may
 contribute to incident wheezing illness in children and adults and cause asthma exacerbations. Although unproven, the increased
 risk of specific respiratory infections in susceptible hosts may contribute to some cases of incident asthma. Vitamin D also
 modulates regulatory T-c...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033306</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:54 +0100</pubDate>
            <guid isPermaLink="false">2033306</guid>        </item>
        <item>
            <title>The problem of anaphylaxis and mastocytosis</title>
            <link>http://www.medworm.com/index.php?rid=2033305&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn0556jg25725866l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mastocytosis is a rare disease characterized by an elevated whole body mast cell number. Anaphylaxis is a severe, generalized
 hypersensitivity reaction with rapid onset. The problem of anaphylaxis and mastocytosis is due to strongly increased mediator
 release from the elevated mast cell number during allergic reactions. This explains the much higher prevalence of anaphylaxis
 in mastocytosis than in the general population and its severe and sometimes fatal course. Because of the increased risk of
 anaphylaxis in mastocytosis, all patients with severe or recurrent anaphylaxis should be analyzed for underlying mastocytosis
 by estimation of baseline serum tryptase. If this is elevated, patients also should be tested via skin examination for cutaneous
 mastocytosis and w...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033305</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:54 +0100</pubDate>
            <guid isPermaLink="false">2033305</guid>        </item>
        <item>
            <title>Oral immunotherapy for food allergy</title>
            <link>http://www.medworm.com/index.php?rid=2033304&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F782881u683l54487%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Current management of food allergy involves strict avoidance, education on recognizing and managing allergic reactions, and
 carrying an adrenaline autoinjector. This approach is burdensome and associated with reduced quality of life. Patients with
 food allergy would benefit greatly from a treatment that could achieve desensitization or long-term tolerance. Recent studies
 have shown that oral immunotherapy (OIT) can induce desensitization and modulate allergen-specific immune responses; however,
 it remains uncertain whether OIT can induce long-term tolerance. Nevertheless, successful desensitization provides a major
 advance in management by reducing the risk of reaction to low amounts of allergen. Allergic reactions during OIT are common,
 although severe reactions ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033304</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:54 +0100</pubDate>
            <guid isPermaLink="false">2033304</guid>        </item>
        <item>
            <title>Bronchial thermoplasty for the treatment of asthma</title>
            <link>http://www.medworm.com/index.php?rid=2033307&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm4562h73j5l86g16%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Asthma is an increasingly prevalent disease, particularly in industrialized countries. With modern treatment, many patients
 can expect good asthma control; however, a significant minority continue to have excessive symptoms. Bronchial thermoplasty
 is a novel approach to treating asthma in which the hypertrophied airway smooth muscle present in the asthmatic airway is
 specifically targeted and depleted using thermal energy. In this article, we review the early animal and human development
 of the technique, summarize the randomized trials carried out in patients to date, discuss proposed mechanisms of action,
 and suggest directions for future work.
 
	Content Type Journal ArticleDOI 10.1007/s11882-009-0013-6Authors
		Neil MartinIan D. Pavord, University Hospitals of ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033307</comments>
            <pubDate>Wed, 10 Dec 2008 07:51:53 +0100</pubDate>
            <guid isPermaLink="false">2033307</guid>        </item>
        <item>
            <title>New types of immunotherapy in children</title>
            <link>http://www.medworm.com/index.php?rid=1984991&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg20v526247588873%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Injection immunotherapy has been shown to be particularly beneficial in treating allergic rhinitis, mild to moderate asthma,
 and anaphylaxis caused by bee and wasp venom. It also produces a long-term, antigen-specific, protective immune effect and
 is the only treatment that offers the possibility of reducing the risk of asthma development in children with allergic rhinitis.
 Nonetheless, the potentially severe side effects associated with this form of immunotherapy limit its widespread use. Diverse
 preparations are being developed to increase its safety and improve its efficacy. These include alternative routes of administration,
 particularly the sublingual route; use of novel adjuvants, such as CpG oligonucleotides and mycobacterial vaccines; and other
 approaches,...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1984991</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:03 +0100</pubDate>
            <guid isPermaLink="false">1984991</guid>        </item>
        <item>
            <title>Subcutaneous and sublingual immunotherapy in children: Complete update on controversies, dosing, and efficacy</title>
            <link>http://www.medworm.com/index.php?rid=1984990&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1mr20793v7q711tq%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;For this review, articles on immunotherapy dosing in pediatric respiratory allergy were identified via PubMed, through congressional
 abstracts for 2008, in reference lists of recent review articles, and via personal communication with experts. In pediatric
 subcutaneous immunotherapy (SCIT), doses shown to be effective, mostly in aluminium-adsorbed preparations administered every
 6 weeks, contain 20 μg of group 5 major allergen, 12 μg Bet v 1, 15 μg Fel d 1, and 5 to 20 μg Der p 1. Evidence indicates
 that SCIT prevents new sensitizations and asthma onset 7 years after discontinuation and reduces symptoms 12 years after a
 5-year SCIT course, even though skin reactivity returns. Consistent evidence of effect exists for sublingual immunotherapy
 in pediatric respir...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1984990</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:03 +0100</pubDate>
            <guid isPermaLink="false">1984990</guid>        </item>
        <item>
            <title>Allergy America</title>
            <link>http://www.medworm.com/index.php?rid=1984989&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh62580151765l6v0%2F</link>
            <description>Content Type Journal ArticleCategory Web AlertDOI 10.1007/s11882-008-0086-7

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 6 / November, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1984989</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:03 +0100</pubDate>
            <guid isPermaLink="false">1984989</guid>        </item>
        <item>
            <title>Otitis media as a presenting complaint in childhood immunodeficiency diseases</title>
            <link>http://www.medworm.com/index.php?rid=1984996&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6626xk35p71621w2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Otitis media is one of the most common childhood infections and may result from a variety of underlying problems. Suspicion
 of immunodeficiency should increase when ear infections are frequent; suppurative; unresponsive to antibiotics; caused by
 unusual organisms; or seen in the context of other frequent infections, severe eczema, or failure to thrive. Humoral immune
 deficiencies, particularly with an inability to make antibody to encapsulated organisms, are the immunodeficiencies most likely
 to cause increased otitis media. Immune system evaluation should concentrate on humoral immunodeficiency disorders, but the
 presenting history and physical findings also should be considered when designing the work-up. Treating the underlying immune
 deficiency is usually nece...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1984996</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:02 +0100</pubDate>
            <guid isPermaLink="false">1984996</guid>        </item>
        <item>
            <title>Small airways disease in asthma</title>
            <link>http://www.medworm.com/index.php?rid=1984995&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx1020j7n8l10t350%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A mounting body of physiologic and pathologic evidence indicates that asthma involves the central and the more distal airways.
 In patients with asthma, the peripheral lung accounts for a significant portion of airway resistance and, similar to the large
 airways, the small airways have been shown to be hyperresponsive to nonspecific stimuli, such as methacholine. Cellular inflammation,
 consisting of an infiltrate rich with lymphocytes and eosinophils, is present in the small airways of patients with asthma
 and may be more intense than that observed in the large airways. Clinical assessment of the peripheral airways continues to
 be a challenge, and new techniques, such as quantitative analysis of chest CT images, have proven to be useful research tools.
 The recognit...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1984995</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:02 +0100</pubDate>
            <guid isPermaLink="false">1984995</guid>        </item>
        <item>
            <title>Eosinophilic otitis media: A new middle ear disease entity</title>
            <link>http://www.medworm.com/index.php?rid=1984994&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxl7708077005h082%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Eosinophilic otitis media (EOM) is intractable otitis media characterized by the presence of a highly viscous yellow effusion
 containing eosinophils. It occurs mainly in patients with bronchial asthma and is resistant to conventional treatments for
 otitis media. Here we discuss the clinical features, pathogenesis, and management of EOM. EOM predominantly affects women
 and presents most often in patients in their 50s. The clinical features of the middle ear in EOM are roughly divided into
 the otitis media with effusion type and chronic otitis media type. The latter is further divided into two subtypes: simple
 perforation and granulation tissue formation. EOM is often complicated by rhinosinusitis (eosinophilic sinusitis). High-tone
 loss is more frequently found and...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1984994</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:02 +0100</pubDate>
            <guid isPermaLink="false">1984994</guid>        </item>
        <item>
            <title>Strategies for primary prevention of atopy in children</title>
            <link>http://www.medworm.com/index.php?rid=1984993&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp183267r55078t37%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In recent decades, the prevalence of atopic diseases such as asthma, hayfever, food allergy, and atopic dermatitis has been
 steadily increasing. Unfortunately, more advances have been made in secondary prevention of symptoms and exacerbations than
 in primary prevention. One barrier to adopting prevention strategies is uncertainty regarding the cause of atopy. A genetic
 predisposition has been well documented. However, other factors, including diet, environment, infections, medications, and
 gastrointestinal flora, all play a role in the development of atopic disease. Modifying these factors holds promise for stopping
 the atopic march in the future. This paper reviews advances that have been made in the primary prevention of atopic disease.
 
	Content Type Journal Ar...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1984993</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:02 +0100</pubDate>
            <guid isPermaLink="false">1984993</guid>        </item>
        <item>
            <title>Allergen tolerance versus the allergic march: The hygiene hypothesis revisited</title>
            <link>http://www.medworm.com/index.php?rid=1984992&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F064u874l28826w27%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In addition to genetics, several environmental variables appear to impact allergic risk. Meta-analyses of epidemiologic studies
 presented in this article demonstrate a correlation between specific ambient exposures (eg, livestock, pets, endotoxin, and
 unpasteurized milk ingestion) and reduced allergic risk during childhood. Additional laboratory investigations discussed in
 this review characterized the intrinsic immunostimulatory activities of living environments. Considered together, results
 of these investigations suggest a novel paradigm by which early-life home exposures to microbial products and other allergen-nonspecific
 immunostimulants modify allergic risk.
 
	Content Type Journal ArticleDOI 10.1007/s11882-008-0088-5Authors
		Kevin TseAnthony A. Horner, Uni...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1984992</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:02 +0100</pubDate>
            <guid isPermaLink="false">1984992</guid>        </item>
        <item>
            <title>Delayed antibiotic therapy for acute otitis media in the emergency department</title>
            <link>http://www.medworm.com/index.php?rid=1985000&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F403j02714u22176l%2F</link>
            <description>Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11882-008-0092-9Authors
		David P. Skoner
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 6 / November, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985000</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:01 +0100</pubDate>
            <guid isPermaLink="false">1985000</guid>        </item>
        <item>
            <title>Pediatric athletic asthmatics</title>
            <link>http://www.medworm.com/index.php?rid=1984999&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl14713v8413j6475%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The main goals of this review are to help the reader to recognize the common symptoms and signs of exercise-induced asthma
 and the common objective tests used to confirm or rule out the diagnosis and to understand that different forms and intensities
 of exercise have different asthmagenicity. The review also aims to help the reader to recognize some of the theories of exercise-induced
 asthma’s pathogenesis, to recognize management strategies (including medications), and to be able to identify medications
 placed on the 2008 prohibited list by the World Anti-Doping Agency and their therapeutic exemptions. It is also important
 to understand that respiratory symptoms associated with exercise are not necessarily asthma and that through safe participation
 in physical ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1984999</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:01 +0100</pubDate>
            <guid isPermaLink="false">1984999</guid>        </item>
        <item>
            <title>Immune modulatory oligonucleotides in the prevention and treatment of allergen-induced eustachian tube dysfunction in the animal model</title>
            <link>http://www.medworm.com/index.php?rid=1984998&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5g351056p75q844p%2F</link>
            <description>This article reviews the current literature investigating the applications and success of immune modulatory oligonucleotides
 as immunotherapy to treat and prevent allergen-induced eustachian tube dysfunction in animal models. Synthetic DNA-based immunotherapy
 agents composed of unmethylated cytosine-guanine dinucleotides (CpG ODNs) that bind to Toll-like receptors have been found
 to have tremendous potential as therapeutic agents and adjuvants. CpG ODNs can induce a shift in the cytokine profile and
 immune response that favors the T-helper type 1 pathway and suppresses the T-helper type 2 pathway. This makes CpG ODNs promising
 candidates for treating allergic diseases. Current CpG ODN studies have demonstrated prevention and treatment of acute allergen
 inflammation of the eustachian ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1984998</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:01 +0100</pubDate>
            <guid isPermaLink="false">1984998</guid>        </item>
        <item>
            <title>Gastric pepsin in middle ear fluid of children with otitis media: Clinical implications</title>
            <link>http://www.medworm.com/index.php?rid=1984997&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm34052l06496w109%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Gastroesophageal reflux and extraesophageal reflux have been postulated to be involved in the pathogenesis of otitis media.
 This is supported by recent studies revealing the presence of gastric pepsin in the middle ear space of children with otitis
 media but not in control patients without otitis media. Reflux’s role in otitis media appears to be most pronounced in younger
 children and those with purulent effusions.
 
	Content Type Journal ArticleDOI 10.1007/s11882-008-0094-7Authors
		Zhaoping HeRobert C. O’Reilly, Alfred I. duPont Hospital for Children Division of Pediatric Otolaryngology 1600 Rockland Road Wilmington DE 19899 USADevendra Mehta
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1984997</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:01 +0100</pubDate>
            <guid isPermaLink="false">1984997</guid>        </item>
        <item>
            <title>Structural aspects of airway remodeling in asthma</title>
            <link>http://www.medworm.com/index.php?rid=1985001&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk9048124g4t0367h%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Airway remodeling in asthma is a complex process that involves structural changes in virtually all tissues of the airway wall.
 The histologic changes to the airways consist of epithelial proliferation and goblet cell differentiation, subepithelial fibrosis,
 airway smooth muscle (ASM) growth, angiogenesis, matrix protein deposition, gland hyperplasia and hypertrophy, and nerve proliferation.
 Cytokines, chemokines, and growth factors from inflammatory cells and structural cells contribute to remodeling. There are
 complex interactions among the various signaling pathways involving matrix metalloproteinases that are required for growth
 factor release. The physiologic consequences of remodeling are airway hyperresponsiveness from ASM growth and mucus hypersecretion
 fro...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1985001</comments>
            <pubDate>Sun, 23 Nov 2008 06:50:00 +0100</pubDate>
            <guid isPermaLink="false">1985001</guid>        </item>
        <item>
            <title>Immunomodulatory treatment for dermatomyositis</title>
            <link>http://www.medworm.com/index.php?rid=1901635&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F70421122583w0386%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Dermatomyositis and polymyositis are classified as members of idiopathic inflammatory myopathies. It has recently become evident
 that the pathogenesis of the muscle disease for these two entities is likely not the same. Despite this observation, therapies
 directed at the muscle disease are similar, although therapy for the skin differs slightly. Corticosteroids remain the initial
 approach to management. The systemic dose of corticosteroids needed to control the disease, particularly the skin disease,
 is quite high; therefore, most authorities add a corticosteroid-sparing agent early. Some patients will naturally “burn out”
 the inflammatory component of their disease, but many have continuing disease activity that requires maintenance therapy.
 In this article, ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901635</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:46 +0100</pubDate>
            <guid isPermaLink="false">1901635</guid>        </item>
        <item>
            <title>Airway wall remodeling in asthma: From the epithelial layer to the adventitia</title>
            <link>http://www.medworm.com/index.php?rid=1901634&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp5gr6vj43tt15861%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Asthma is an episodic respiratory syndrome caused by several pathogenic processes. This recurrent syndrome is associated with
 an accelerated decline in lung function and increase in airway obstruction over time. The reduced lung function is a consequence
 of tissue restructuring of all the components of the airway wall: 1) epithelium metaplasia; 2) altered quantity, composition,
 and distribution of extracellular matrix components; 3) microvascular remodeling; and 4) increase of airway smooth muscle
 mass. How these structural changes affect lung functions is not entirely clear. Deeper understandings of the altered structure
 and related functional impairment are important for gaining insights into the mechanisms underlying asthma. This review describes
 the tissue rem...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901634</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:46 +0100</pubDate>
            <guid isPermaLink="false">1901634</guid>        </item>
        <item>
            <title>Expanding roles for leukotrienes in airway inflammation</title>
            <link>http://www.medworm.com/index.php?rid=1901633&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp557q32l67233431%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Leukotrienes (LTs) are lipid mediators derived from the 5-lipoxygenase pathway of arachidonic acid metabolism. Cysteinyl (cys)
 LTs C4, D4, and E4 are long known to contribute to airway contractile responses via ligation of the cysLT1 receptor, and cysLT1 antagonists
 are beneficial in some patients with asthma. Research advances over the past several years suggest that cysLT1 also mediates
 the ability of cysLTs to modulate inflammation, immune responses, and airway remodeling. Although less is known about an additional
 receptor, cysLT2, emerging evidence indicates that it likely also contributes to cysLT actions promoting inflammation, vascular
 permeability, and perhaps fibrosis. LTB4, best known as a neutrophil chemoattractant, is now recognized to exert other impo...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901633</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:46 +0100</pubDate>
            <guid isPermaLink="false">1901633</guid>        </item>
        <item>
            <title>Neuro-ophthalmic complications in giant cell arteritis</title>
            <link>http://www.medworm.com/index.php?rid=1901638&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F555023712v8t4l64%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Giant cell arteritis (GCA) is a medical emergency characterized by systemic inflammation and critical ischemia. Neuro-ophthalmic
 complications occur early, with permanent vision loss in up to one fifth of patients. This mainly results from failure of
 prompt recognition and treatment. Diagnosis of GCA is often preceded by unrecognized symptoms, including constitutional upset
 and jaw claudication. Features predictive of permanent visual loss include jaw claudication and temporal artery abnormalities
 on physical examination. These patients often do not mount high inflammatory responses. Modern imaging techniques show diagnostic
 promise, and have led to an increased recognition of major artery involvement in GCA. However, temporal artery biopsy remains
 the gold standa...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901638</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:45 +0100</pubDate>
            <guid isPermaLink="false">1901638</guid>        </item>
        <item>
            <title>Biologic agents in the management of inflammatory eye diseases</title>
            <link>http://www.medworm.com/index.php?rid=1901637&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fen2438588w84270n%2F</link>
            <description>This article
 reviews the rationale and current evidence for their use in uveitis, scleritis, and orbital inflammation.
 
	Content Type Journal ArticleDOI 10.1007/s11882-008-0054-2Authors
		Kira MichalovaLyndell Lim, University of Melbourne Macular Research Unit, Centre for Eye Research Australia 32 Gisborne Street East Melbourne Victoria 3002 Australia
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 4 / July, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901637</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:45 +0100</pubDate>
            <guid isPermaLink="false">1901637</guid>        </item>
        <item>
            <title>Intraocular inflammation: Its causes and investigations</title>
            <link>http://www.medworm.com/index.php?rid=1901636&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe8731667293q76t6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Intraocular inflammation, or uveitis, incorporates a diverse group of infectious and immune-mediated disorders. In addition,
 some conditions masquerade as uveitis. However, classifying uveitis according to anatomic location in adult and pediatric
 populations, and appreciating the effect of immune status and regional differences, refines the list of potential causes.
 In this way, a select few investigations can be performed, rather than a nondirected battery of tests.
 
	Content Type Journal ArticleDOI 10.1007/s11882-008-0053-3Authors
		Claire HooperPeter McCluskey, 45-47 Goulburn Street Liverpool NSW 2170 Australia
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number ...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901636</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:45 +0100</pubDate>
            <guid isPermaLink="false">1901636</guid>        </item>
        <item>
            <title>Skin barrier function</title>
            <link>http://www.medworm.com/index.php?rid=1901642&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3q488377u0737428%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Like other inflammatory dermatoses, the pathogenesis of atopic dermatitis (AD) has been largely attributed to abnormalities
 in adaptive immunity. T helper (Th) cell types 1 and 2 cell dysregulation, IgE production, mast cell hyperactivity, and dendritic
 cell signaling are thought to account for the chronic, pruritic, and inflammatory dermatosis that characterizes AD. Not surprisingly,
 therapy has been directed toward ameliorating Th2-mediated inflammation and pruritus. Here, we review emerging evidence that
 inflammation in AD occurs downstream to inherited and acquired insults to the barrier. Therapy based upon this new view of
 pathogenesis should emphasize approaches that correct the primary abnormality in barrier function, which drives downstream
 inflammation an...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901642</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:44 +0100</pubDate>
            <guid isPermaLink="false">1901642</guid>        </item>
        <item>
            <title>What causes itch in atopic dermatitis?</title>
            <link>http://www.medworm.com/index.php?rid=1901641&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb6283r5738428n74%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Itch, the hallmark of atopic dermatitis, has a significant impact on quality of life for patients with this disease. Various
 central and peripheral mediators have been suggested to play a role in the pathophysiology of atopic eczema itch. Significant
 cross-talk occurs among stratum corneum, keratinocytes, immune cells, and nerve fibers, which are in close proximity to one
 another and induce itch. The impaired barrier function associated with the itch-scratch cycle further augments this vicious
 cycle. Recent advances in our understanding of itch pathophysiology shed light on peripheral and central neural sensitization
 of nerve fibers that contribute significantly to itch in atopic dermatitis. Recently, several new mediators have been described
 as associated with it...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901641</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:44 +0100</pubDate>
            <guid isPermaLink="false">1901641</guid>        </item>
        <item>
            <title>Stress and atopic dermatitis</title>
            <link>http://www.medworm.com/index.php?rid=1901640&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc4k1wm82872802n1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Atopic dermatitis (AD) is a complex disease traditionally involving interaction of genetic, environmental, and immunologic
 factors. Recent studies suggest psychoneuro-immunologic factors and emotional stress are important in its evolution. The observations
 that internal (bacterial infections) or external (psychologic) stressors may induce AD flares is explained by studies showing
 that stress impairs the skin barrier function and favors a shift in immunity toward a T helper type 2 cell/allergic response.
 Furthermore, those with AD appear to have an inherited hypothalamic deficiency that impairs normal hypothalamic-pituitary-adrenal
 axis function. Neuropeptides released in the skin may also mediate neurogenic inflammation, including mast cell degranulation.
 AD cause...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901640</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:44 +0100</pubDate>
            <guid isPermaLink="false">1901640</guid>        </item>
        <item>
            <title>Clinical trials report</title>
            <link>http://www.medworm.com/index.php?rid=1901639&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc15m725670g7x40w%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11882-008-0051-5Authors
		Constance H. Katelaris
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 4 / July, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901639</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:44 +0100</pubDate>
            <guid isPermaLink="false">1901639</guid>        </item>
        <item>
            <title>The spectrum of monogenic autoinflammatory syndromes: Understanding disease mechanisms and use of targeted therapies</title>
            <link>http://www.medworm.com/index.php?rid=1901643&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhw3164523227133r%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Monogenic autoinflammatory diseases encompass a distinct and growing clinical entity of multisystem inflammatory diseases
 with known genetic defects in the innate immune system. The diseases present clinically with episodes of seemingly unprovoked
 inflammation (fever, rashes, and elevation of acute phase reactants). Understanding the genetics has led to discovery of new
 molecules involved in recognizing exogenous and endogenous danger signals, and the inflammatory response to these stimuli.
 These advances have furthered understanding of innate inflammatory pathways and spurred collaborative research in rheumatology
 and infectious diseases. The pivotal roles of interleukin (IL)-1β in cryopyrin-associated periodic syndromes, tumor necrosis
 factor (TNF) in TNF recep...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901643</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:43 +0100</pubDate>
            <guid isPermaLink="false">1901643</guid>        </item>
        <item>
            <title>Immunomodulatory approaches to the management of chronic urticaria: An immune-mediated inflammatory disease</title>
            <link>http://www.medworm.com/index.php?rid=1901644&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq77725782347h061%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although commonly encountered in clinical practice, chronic urticaria (CU) remains difficult to treat. In contrast to acute
 urticaria, neither exogenous triggers nor specific immunoglobulin E are identified in most chronic cases. A body of evidence
 suggests that CU is represented within the spectrum of immune-mediated inflammatory diseases (IMID). Our understanding of
 the CU disease pathogenesis now recognizes a role for T cells, B cells, and autoantibodies, and intrinsic abnormalities of
 histamine-releasing effector cells, thus providing new targets of intervention beyond the current mainstay of often inadequate
 symptomatic treatment directed against histamine receptors and steroids, with their attendant morbidities. Agents previously
 used to treat other autoimmu...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901644</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:42 +0100</pubDate>
            <guid isPermaLink="false">1901644</guid>        </item>
        <item>
            <title>Web alert</title>
            <link>http://www.medworm.com/index.php?rid=1901645&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F012n6q600p62j577%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11882-008-0045-3Authors
		Lyndon E. Mansfield, Texas Tech University Health Sciences Center-El Paso Director Western Sky Medical Research 1901 Arizona Avenue El Paso TX 79902 USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 4 / July, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901645</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:41 +0100</pubDate>
            <guid isPermaLink="false">1901645</guid>        </item>
        <item>
            <title>Recent advances in immunotherapy of allergic rhinitis</title>
            <link>http://www.medworm.com/index.php?rid=1901646&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpg1370788t338134%2F</link>
            <description>Content Type Journal ArticleCategory Invited CommentaryDOI 10.1007/s11882-008-0044-4Authors
		Chul Hee Lee, Seoul National University College of Medicine, Seoul National University Bundang Hospital Department of Otorhinolaryngology 300 Gumi-dong Bundang-gu, Seongnam-si Gyeonggi-do 464-707 South KoreaJi-Hun Mo
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 4 / July, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901646</comments>
            <pubDate>Tue, 21 Oct 2008 14:41:40 +0100</pubDate>
            <guid isPermaLink="false">1901646</guid>        </item>
        <item>
            <title>Management of allergic aspergillosis</title>
            <link>http://www.medworm.com/index.php?rid=1833282&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3022wl6557tw2806%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Treatment of allergic bronchopulmonary aspergillosis depends on accurate diagnosis, which is difficult because of multiple
 clinical, radiographic, and immunologic criteria; unstandardized immunoassays; and its similarity to cystic fibrosis. Advances
 in chest CT interpretation, measuring serum Aspergillus fumigatus-specific antibodies and the T-helper type 2 chemokine thymus-activated-and-regulated chemokine, recognizing risk factors,
 should improve diagnostic accuracy. Oral glucocorticosteroids remain the mainstay of treatment. Dose regimen and duration
 are not standardized, so expert recommendations are used. Inhaled steroids have not been proven to be effective. Due to relapse
 and toxicity, itraconazole has been added as second-tier therapy, supported by randomiz...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833282</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:24 +0100</pubDate>
            <guid isPermaLink="false">1833282</guid>        </item>
        <item>
            <title>Pollen food syndrome: Update on the allergens</title>
            <link>http://www.medworm.com/index.php?rid=1833285&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh48w280333712w67%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pollen food syndrome results from cross-reactivity between pollen-specific IgE and homologous proteins found in fruits and
 vegetables. These proteins can be grouped into several categories based on structure and include profilins, pathogenesis-related
 proteins, and cross-reactive carbohydrate determinants. Although cooking the reactive fruits and vegetables has been shown
 to destroy IgE-binding epitopes, evidence suggests that the remaining linear epitopes can bind cross-reactive T cells and
 enhance T-cell activation in vitro. Several methods of diagnosing food allergies exist, including skin prick tests and double-blind
 food challenges; however, diagnosing pollen food syndrome depends almost exclusively on clinical history. Immunotherapy has
 been studied as a tre...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833285</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:23 +0100</pubDate>
            <guid isPermaLink="false">1833285</guid>        </item>
        <item>
            <title>Changing pollen types/concentrations/distribution in the United States: Fact or fiction?</title>
            <link>http://www.medworm.com/index.php?rid=1833284&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr6707406jm72ht23%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The buildup of greenhouse gases in the atmosphere has resulted in global climate change that is having a significant effect
 on many allergenic plants through increases in plant productivity and pollen allergenicity and shifts in plant phenology.
 Based on experimental studies, increased atmospheric levels of carbon dioxide have directly increased plant productivity.
 This has affected the total amount of pollen produced in some species. Research has also shown increased levels of birch allergen
 at warmer temperatures. Warmer temperatures have resulted in earlier flowering for many spring-flowering species in many countries,
 recorded through visual observations of flowering and by airborne pollen. Increases in the cumulative season totals of various
 pollen types also...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833284</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:23 +0100</pubDate>
            <guid isPermaLink="false">1833284</guid>        </item>
        <item>
            <title>Allergen structures and biologic functions: The cutting edge of allergy research</title>
            <link>http://www.medworm.com/index.php?rid=1833283&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa1u6x02521721126%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Studies of structure and function of allergens using state-of-the-art technologies have led to a better understanding of allergenicity,
 including aspects related to cross-reactivity, allergen nomenclature, and the identification of antigenic determinants. This
 information is being applied to the design and production of allergy vaccines, some of which already have proven efficacy
 and safety in clinical trials.
 
	Content Type Journal ArticleDOI 10.1007/s11882-008-0082-yAuthors
		Anna Pomés, Indoor Biotechnologies 1216 Harris Street Charlottesville VA 22903 USA
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 5 / September, 2008 (Source: Current Allergy and Asthma...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833283</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:23 +0100</pubDate>
            <guid isPermaLink="false">1833283</guid>        </item>
        <item>
            <title>STAT4
 : Genetics, mechanisms, and implications for autoimmunity</title>
            <link>http://www.medworm.com/index.php?rid=1833288&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F89617513k2v30053%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent advances in genetics and technology have led to breakthroughs in understanding the genes that predispose individuals
 to autoimmune diseases. A common haplotype of the signal transducer and activator of transcription 4 (STAT4) gene has been shown to be associated with susceptibility to rheumatoid arthritis, systemic lupus erythematosus, and primary
 Sjögren’s syndrome. STAT4 is a transcription factor that transduces interleukin-12, interleukin-23, and type 1 interferon cytokine signals in T cells
 and monocytes, leading to T-helper type 1 and T-helper type 17 differentiation, monocyte activation, and interferon-γ production.
 Although the evidence for this association is very strong and well replicated, the exact mechanism by which polymorphisms
 in this gene...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833288</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:22 +0100</pubDate>
            <guid isPermaLink="false">1833288</guid>        </item>
        <item>
            <title>Clinical trials report</title>
            <link>http://www.medworm.com/index.php?rid=1833287&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0744248843882247%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11882-008-0079-6Authors
		Robert K. Bush
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 5 / September, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833287</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:22 +0100</pubDate>
            <guid isPermaLink="false">1833287</guid>        </item>
        <item>
            <title>The role of chemokines in virus-associated asthma exacerbations</title>
            <link>http://www.medworm.com/index.php?rid=1833286&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1472333578725021%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Asthma is a chronic disease characterized by mast cell activation, mucus hypersecretion, airway obstruction, influx and activation
 of eosinophils, and generation of a predominant T-helper type 2-based cytokine environment. In individuals with established
 asthma, acute exacerbations requiring hospitalization result primarily from pulmonary viral infection, such as with influenza,
 rhinovirus, or respiratory syncytial virus. The mechanism for viral exacerbation of the asthmatic response is unclear, but
 evidence points to a key role for chemokines, a class of cytokines that are important in leukocyte recruitment, inflammatory
 cell activation, and T-cell differentiation. In this review, we focus on the chemokines upregulated in acute viral-induced
 exacerbation and exam...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833286</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:22 +0100</pubDate>
            <guid isPermaLink="false">1833286</guid>        </item>
        <item>
            <title>Clinical trials report</title>
            <link>http://www.medworm.com/index.php?rid=1833291&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx2u15j8p2t237602%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11882-008-0074-yAuthors
		Sapandeep K. SinghDalia G. GaliciaDavid P. Huston
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 5 / September, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833291</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:21 +0100</pubDate>
            <guid isPermaLink="false">1833291</guid>        </item>
        <item>
            <title>Genetic origins of hyper-IgE syndrome</title>
            <link>http://www.medworm.com/index.php?rid=1833290&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7rm1n718q742v616%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hyper-IgE syndrome (HIES) is a complex primary immunodeficiency characterized by high serum IgE, chronic eczematoid dermatitis,
 and recurrent extracellular bacterial infections. Two types of HIES have been reported: type 1 and type 2. Type 1 HIES displays
 abnormalities in multiple systems, including the skeletal, dental, and immune systems, whereas type 2 shows abnormalities
 confined to the immune system. We recently identified hypomorphic mutations in the signal transducer and activator of transcription
 3 (STAT3) gene in type 1 HIES and a null mutation in the tyrosine kinase 2 (Tyk2) gene, accompanied by susceptibility to intracellular bacteria in type 2 HIES. Analyses of cytokine responses in both types
 of HIES revealed that severe defects in the signal transduct...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833290</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:21 +0100</pubDate>
            <guid isPermaLink="false">1833290</guid>        </item>
        <item>
            <title>Parasitic nematode modulation of allergic disease</title>
            <link>http://www.medworm.com/index.php?rid=1833289&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp40586n201760g57%2F</link>
            <description>This article reviews the evidence
 to support this idea, considering data from human studies and results from investigations into the protective effects of nematodes
 in animal models of allergic disease. The evidence strongly favors a protective role for nematodes; thus, the search is on
 to find the molecules involved, with a view toward using them for therapeutic purposes. The article also describes the nature
 and mode of action of recently characterized nematode-derived molecules with antiallergic properties and highlights their
 therapeutic efficacy in allergy models.
 
	Content Type Journal ArticleDOI 10.1007/s11882-008-0076-9Authors
		William Harnett, University of Strathclyde Strathclyde Institute of Pharmacy and Biomedical Sciences 27 Taylor Street Glasgow G4 0NR UKMargaret M. Ha...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833289</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:21 +0100</pubDate>
            <guid isPermaLink="false">1833289</guid>        </item>
        <item>
            <title>Web alert</title>
            <link>http://www.medworm.com/index.php?rid=1833293&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F64926300th571243%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11882-008-0073-z

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 5 / September, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833293</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:20 +0100</pubDate>
            <guid isPermaLink="false">1833293</guid>        </item>
        <item>
            <title>IgE-mediated anaphylactic reactions to neuromuscular blocking agents: Can they be prevented?</title>
            <link>http://www.medworm.com/index.php?rid=1833292&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnx34735704612758%2F</link>
            <description>Content Type Journal ArticleCategory Invited CommentaryDOI 10.1007/s11882-008-0072-0Authors
		E. FlorvaagS. G. O. Johansson, Karolinska University Hospital Department of Clinical Immunology Solna, L2:04 S-171 76 Stockholm Sweden
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 5 / September, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833292</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:20 +0100</pubDate>
            <guid isPermaLink="false">1833292</guid>        </item>
        <item>
            <title>Autosomal recessive agammaglobulinemia: Novel insights from mutations in Ig-beta</title>
            <link>http://www.medworm.com/index.php?rid=1833294&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm475253696416261%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Agammaglobulinemia is a rare primary immunodeficiency characterized by an early block of B-cell development in the bone marrow
 resulting in the absence of peripheral B cells and low/absent immunoglobulin serum levels. Mutations in the Bruton tyrosine
 kinase and in components of the pre-B-cell receptor (pre-BCR), such as μ heavy chain, surrogate light chain, and Igα have
 been found in 85% to 90% of patients affected by this disease. Here we review the recent advances in the characterization
 of molecular defects underlying an early block in B-cell development, focusing on the novel finding of the first two patients
 with agammaglobulinemia caused by mutations in Igβ, the transmembrane protein that associates with Igα as part of the pre-BCR
 complex. Characterizati...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833294</comments>
            <pubDate>Thu, 25 Sep 2008 07:33:18 +0100</pubDate>
            <guid isPermaLink="false">1833294</guid>        </item>
        <item>
            <title>Innate immune mechanism in allergic asthma</title>
            <link>http://www.medworm.com/index.php?rid=1833295&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftkh418962520w076%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Allergic asthma is a chronic inflammatory disorder of the airways characterized by eosinophilic inflammation, airway hyperresponsiveness,
 and mucus hypersecretion. Adaptive, antigen-dependent immunity is critical for asthma pathogenesis. Allergic asthma may involve
 adaptive and innate, antigen-independent immune responses. This review discusses the current evidence that associates innate
 immunity with allergic asthma pathogenesis. In particular, we focus on the role of innate immune cells (eg, bronchial epithelial
 cells, alveolar macrophages, and dendritic cells) and molecules (Toll-like and nucleotide-binding oligomerization domain-like
 receptors) in modifying allergic immune responses.
 
	Content Type Journal ArticleDOI 10.1007/s11882-008-0085-8Authors
		Carlos J...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1833295</comments>
            <pubDate>Thu, 25 Sep 2008 07:23:59 +0100</pubDate>
            <guid isPermaLink="false">1833295</guid>        </item>
        <item>
            <title>Addressing the psychological needs of families of food-allergic children</title>
            <link>http://www.medworm.com/index.php?rid=1419108&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn7r270328u1p31qj%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The increase in food allergies among US children has led to greater awareness of the psychological impact on their families.
 A variety of negative effects can result from both the daily strain of food-allergy management and the constant vigilance
 and fear that this condition engenders. Most of these effects are normal and expected responses to having a child with a demanding
 condition filled with uncertainties. However, a small but substantial proportion of families living with childhood food allergy
 experience significant psychological distress and/or maladaptive coping responses that interfere with the child’s psychological
 and social development and family members’ optimal functioning. Health care providers must be aware of the psychological challenges
 thes...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1419108</comments>
            <pubDate>Fri, 02 May 2008 05:40:59 +0100</pubDate>
            <guid isPermaLink="false">1419108</guid>        </item>
        <item>
            <title>Clinical Trials Report</title>
            <link>http://www.medworm.com/index.php?rid=1419110&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6u3nx26p2832214m%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11882-008-0031-9Authors
		Dan Atkins
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 3 / May, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1419110</comments>
            <pubDate>Fri, 02 May 2008 05:40:57 +0100</pubDate>
            <guid isPermaLink="false">1419110</guid>        </item>
        <item>
            <title>The role of food allergy in atopic dermatitis</title>
            <link>http://www.medworm.com/index.php?rid=1419109&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe463k422t2116154%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Atopic dermatitis (AD) is a chronic, pruritic, inflammatory skin disease affecting more than 10% of all children. Sensitization
 to foods triggers isolated skin symptoms in about 30% of children. These symptoms include immediate reactions within minutes
 after ingesting food without exacerbation of AD and early and late exacerbations of AD. It is important to identify clinically
 relevant sensitizations to foods using skin prick tests, a specific IgE blood test (ImmunoCAP; Phadia, Portage, MI, USA),
 and double-blind, placebo-controlled food challenges to initiate appropriate dietary interventions and avoid unnecessary dietary
 restrictions. Children with AD triggered by food allergens demonstrate a distinct immune response upon stimulation of their
 peripheral blood mo...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1419109</comments>
            <pubDate>Fri, 02 May 2008 05:40:57 +0100</pubDate>
            <guid isPermaLink="false">1419109</guid>        </item>
        <item>
            <title>Omalizumab for patients with severe and therapy-refractory atopic eczema?</title>
            <link>http://www.medworm.com/index.php?rid=1419112&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm426m54623727516%2F</link>
            <description>Content Type Journal ArticleCategory Invited CommentaryDOI 10.1007/s11882-008-0029-3Authors
		Christian Andres, Technical University Munich Department of Dermatology and Allergy Biedersteiner Strasse 29 80802 Munich GermanyBenedetta BelloniMartin MempelJohannes Ring
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 3 / May, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1419112</comments>
            <pubDate>Fri, 02 May 2008 05:40:56 +0100</pubDate>
            <guid isPermaLink="false">1419112</guid>        </item>
        <item>
            <title>Web alert</title>
            <link>http://www.medworm.com/index.php?rid=1419111&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwpw33273773062q3%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11882-008-0030-x

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 3 / May, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1419111</comments>
            <pubDate>Fri, 02 May 2008 05:40:56 +0100</pubDate>
            <guid isPermaLink="false">1419111</guid>        </item>
        <item>
            <title>Primary asthma prevention: Is it possible?</title>
            <link>http://www.medworm.com/index.php?rid=1419114&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F52l52586434j9218%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Asthma, which typically begins in childhood and is the most common chronic disease of childhood, has reached epidemic proportions.
 Asthma is associated with gene-environment interactions, and there is consensus that a “window of opportunity” exists early
 in life when environmental factors may influence its development. This review considers biologic and sociologic factors in
 the development of allergy and asthma. Meta-analysis of studies demonstrates that monoallergen reduction does not impact asthma
 prevention. However, multifaceted allergen reduction studies have shown clinical benefit. We propose that allergic diseases,
 including asthma, represent a dysfunctional interaction with our environment and that the increasing prevalence of asthma
 and allergy heral...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1419114</comments>
            <pubDate>Fri, 02 May 2008 05:40:55 +0100</pubDate>
            <guid isPermaLink="false">1419114</guid>        </item>
        <item>
            <title>ENT manifestations of gastroesophageal reflux</title>
            <link>http://www.medworm.com/index.php?rid=1419113&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd282142m044x378l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Gastroesophageal reflux (GER) has been associated with a variety of supraesophageal symptoms or diseases, including chronic
 cough, laryngeal disorders, rhinosinusitis, otitis media, and oral cavity lesions. In this article, we review the relationship
 between GER and ear, nose, and throat (ENT) symptoms. Data in the published literature are frequently conflicting. Only a
 few studies are controlled, and an evidence-based approach provides weak support for a causal association between GER and
 ENT manifestations. The GER diagnostic method should be standardized utilizing new parameters, and the definition and diagnostic
 accuracy of ENT pathologies also must be better specified. A firm connection remains controversial, and further randomized
 trials are needed.
 
	Conte...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1419113</comments>
            <pubDate>Fri, 02 May 2008 05:40:55 +0100</pubDate>
            <guid isPermaLink="false">1419113</guid>        </item>
        <item>
            <title>The role of bacterial biofilms and the pathophysiology of chronic rhinosinusitis</title>
            <link>http://www.medworm.com/index.php?rid=1419116&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl7q1766276870632%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The earliest description of a bacterial biofilm is likely centuries old. However, only in the past few decades has a wealth
 of knowledge developed pertaining to this bacterial form of existence. Biofilms have been implicated mainly in chronic disease
 states, and the current available treatment modalities for infection have demonstrated limited efficacy against bacteria in
 this form. There is evidence associating bacterial biofilm formation in chronic infections of the upper airway, and therefore
 we examine the possible role of a bacterial biofilm in chronic rhinosinusitis while drawing parallels with recent data from
 other bodily regions. Lastly, directions for contemporary biofilm research are reviewed and highlighted in terms of their
 application to chronic rhin...</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1419116</comments>
            <pubDate>Fri, 02 May 2008 05:40:54 +0100</pubDate>
            <guid isPermaLink="false">1419116</guid>        </item>
        <item>
            <title>Cyclooxygenases and the pathogenesis of chronic rhinosinusitis and nasal polyposis</title>
            <link>http://www.medworm.com/index.php?rid=1419115&amp;cid=s_35927_3_f&amp;fid=35927&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv4j8x356l06qk473%2F</link>
            <description>This article focuses on COX in the pathogenesis of chronic rhinosinusitis
 and nasal polyposis.
 
	Content Type Journal ArticleDOI 10.1007/s11882-008-0037-3Authors
		Josep M. GuilemanyJordi Roca-FerrerJoaquim Mullol, Hospital Clínic i Universitari c/Villarroel Rhinology Unit and Smell Clinic, Department of Otorhinolaryngology 170, Barcelona 08036 Catalunya Spain
	

	
		Journal Current Allergy and Asthma ReportsOnline ISSN 1534-6315Print ISSN 1529-7322
	
		Journal Volume Volume 8
	
		Journal Issue Volume 8, Number 3 / May, 2008 (Source: Current Allergy and Asthma Reports)</description>
            <author>Current Allergy and Asthma Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1419115</comments>
            <pubDate>Fri, 02 May 2008 05:40:54 +0100</pubDate>
            <guid isPermaLink="false">1419115</guid>        </item>
    </channel>
</rss>
